<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Viruses</journal-id><journal-id journal-id-type="iso-abbrev">Viruses</journal-id><journal-id journal-id-type="publisher-id">viruses</journal-id><journal-title-group><journal-title>Viruses</journal-title></journal-title-group><issn pub-type="epub">1999-4915</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11680275</article-id><article-id pub-id-type="doi">10.3390/v16121870</article-id><article-id pub-id-type="publisher-id">viruses-16-01870</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Rewriting Viral Fate: Epigenetic and Transcriptional Dynamics in KSHV Infection</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Han</surname><given-names>Chunyan</given-names></name><xref rid="af1-viruses-16-01870" ref-type="aff">1</xref><xref rid="fn1-viruses-16-01870" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Niu</surname><given-names>Danping</given-names></name><xref rid="af1-viruses-16-01870" ref-type="aff">1</xref><xref rid="fn1-viruses-16-01870" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0384-8598</contrib-id><name><surname>Lan</surname><given-names>Ke</given-names></name><xref rid="af1-viruses-16-01870" ref-type="aff">1</xref><xref rid="af2-viruses-16-01870" ref-type="aff">2</xref><xref rid="af3-viruses-16-01870" ref-type="aff">3</xref><xref rid="c1-viruses-16-01870" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Toth</surname><given-names>Zsolt</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-viruses-16-01870"><label>1</label>State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan 430072, China; <email>chunyanhan@whu.edu.cn</email> (C.H.); <email>danpingniu@whu.edu.cn</email> (D.N.)</aff><aff id="af2-viruses-16-01870"><label>2</label>Department of Infectious Diseases, Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430072, China</aff><aff id="af3-viruses-16-01870"><label>3</label>Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan 430072, China</aff><author-notes><corresp id="c1-viruses-16-01870"><label>*</label>Correspondence: <email>klan@whu.edu.cn</email></corresp><fn id="fn1-viruses-16-01870"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>30</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><volume>16</volume><issue>12</issue><elocation-id>1870</elocation-id><history><date date-type="received"><day>06</day><month>11</month><year>2024</year></date><date date-type="rev-recd"><day>27</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>28</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Kaposi&#x02019;s sarcoma-associated herpesvirus (KSHV), a &#x003b3;-herpesvirus, is predominantly associated with Kaposi&#x02019;s sarcoma (KS) as well as two lymphoproliferative disorders: primary effusion lymphoma (PEL) and multicentric Castleman disease (MCD). Like other herpesviruses, KSHV employs two distinct life cycles: latency and lytic replication. To establish a lifelong persistent infection, KSHV has evolved various strategies to manipulate the epigenetic machinery of the host. In latently infected cells, most viral genes are epigenetically silenced by components of cellular chromatin, DNA methylation and histone post-translational modifications. However, some specific latent genes are preserved and actively expressed to maintain the virus&#x02019;s latent state within the host cell. Latency is not a dead end, but the virus has the ability to reactivate. This reactivation is a complex process that involves the removal of repressive chromatin modifications and increased accessibility for both viral and cellular factors, allowing the activation of the full transcriptional program necessary for the subsequent lytic replication. This review will introduce the roles of epigenetic modifications in KSHV latent and lytic life cycles, including DNA methylation, histone methylation and acetylation modifications, chromatin remodeling, genome conformation, and non-coding RNA expression. Additionally, we will also review the transcriptional regulation of viral genes and host factors in KSHV infection. This review aims to enhance our understanding of the molecular mechanisms of epigenetic modifications and transcriptional regulation in the KSHV life cycle, providing insights for future research.</p></abstract><kwd-group><kwd>KSHV</kwd><kwd>life cycle</kwd><kwd>epigenetic modifications</kwd><kwd>transcriptional regulation</kwd></kwd-group><funding-group><award-group><funding-source>Natural Science Foundation of China</funding-source><award-id>81930060</award-id><award-id>32188101</award-id></award-group><funding-statement>This work was supported by the grants from the Natural Science Foundation of China (81930060, 32188101) to K.L.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-viruses-16-01870"><title>1. Introduction</title><p>Kaposi&#x02019;s sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8, was identified as a human cancer-associated virus in 1994 by Drs. Yuan Chang and Patrick Moore [<xref rid="B1-viruses-16-01870" ref-type="bibr">1</xref>]. Various lymphocytic and epithelial malignancies can be directly associated with KSHV infection, including Kaposi&#x02019;s sarcoma (KS), primary effusion lymphoma (PEL), multicentric Castleman disease (MCD), and an inflammatory syndrome known as KSHV inflammatory cytokine syndrome (KICS) [<xref rid="B1-viruses-16-01870" ref-type="bibr">1</xref>,<xref rid="B2-viruses-16-01870" ref-type="bibr">2</xref>,<xref rid="B3-viruses-16-01870" ref-type="bibr">3</xref>,<xref rid="B4-viruses-16-01870" ref-type="bibr">4</xref>]. KSHV is a large double-stranded DNA virus (~165 kb), and its genome encodes approximately 90 viral proteins and non-coding RNAs [<xref rid="B5-viruses-16-01870" ref-type="bibr">5</xref>,<xref rid="B6-viruses-16-01870" ref-type="bibr">6</xref>]. Like other herpesviruses, KSHV has a biphasic life cycle, a quiescent latent phase, and a lytic replication phase. During latency, the KSHV genome is transported into the cell nucleus, where it circularizes into a mini chromosome, known as an episome [<xref rid="B7-viruses-16-01870" ref-type="bibr">7</xref>,<xref rid="B8-viruses-16-01870" ref-type="bibr">8</xref>]. The episomal KSHV DNA resides in the nucleus bound to histone and non-histone proteins. This association indicates that epigenetic modifications&#x02014;including DNA methylation, histone modifications, interactions with non-coding RNAs, and chromatin remodeling factors&#x02014;may impact its activity and regulate viral gene expression. It has been suggested that only limited viral proteins and microRNAs are expressed during latency, including ORF73/LANA (latency-associated nuclear antigen), ORF72/v-Cyclin (virus-encoded homolog of human cyclin D), ORF71/v-FLIP (Fas-associated death domain-like interleukin-1&#x003b2;-converting enzyme-inhibitory protein) and K12/Kaposin family of protein (Kaposin A, B, and C) along with 25 mature microRNAs [<xref rid="B9-viruses-16-01870" ref-type="bibr">9</xref>]. Latently infected cells can endure reactivation in response to various exogenous stimuli, which transitions the virus from latency to lytic replication [<xref rid="B10-viruses-16-01870" ref-type="bibr">10</xref>,<xref rid="B11-viruses-16-01870" ref-type="bibr">11</xref>]. Studies have indicated that inhibitors of histone deacetylases (HDACs) and DNA methyltransferases (DNMTs) can activate the expression of KSHV genes, highlighting the crucial roles of DNA methylation and histone modifications in gene regulation [<xref rid="B11-viruses-16-01870" ref-type="bibr">11</xref>,<xref rid="B12-viruses-16-01870" ref-type="bibr">12</xref>]. During lytic replication, the entire viral genome is expressed in a temporally regulated transcriptional cascade. This process features the sequential activation of three classes of lytic genes: immediate early (IE), early (E), and late (L) genes [<xref rid="B13-viruses-16-01870" ref-type="bibr">13</xref>].</p><p>Besides epigenetic modifications that can alter the fate of KSHV, various viral and host transcriptional factors also play crucial roles in regulating the life cycle of KSHV. On one hand, differences in gene expression between the latent and lytic phases of KSHV are partially regulated by host transcription factors such as transcriptional co-activators and repressors. These factors, such as the nuclear factor kappa B (NF-&#x003ba;B) signaling pathway [<xref rid="B14-viruses-16-01870" ref-type="bibr">14</xref>], specificity protein 1 (SP1) [<xref rid="B15-viruses-16-01870" ref-type="bibr">15</xref>], activator protein 1 (AP-1) [<xref rid="B16-viruses-16-01870" ref-type="bibr">16</xref>], signal transducer and activator of transcription 3 (STAT3) [<xref rid="B17-viruses-16-01870" ref-type="bibr">17</xref>], octamer-binding transcription factor 1 (Oct-1) [<xref rid="B18-viruses-16-01870" ref-type="bibr">18</xref>], Yin Yang 1 (YY1) [<xref rid="B19-viruses-16-01870" ref-type="bibr">19</xref>], Kr&#x000fc;ppel-associated box domain-associated protein 1 (KAP1) [<xref rid="B20-viruses-16-01870" ref-type="bibr">20</xref>], TLE2 [<xref rid="B21-viruses-16-01870" ref-type="bibr">21</xref>], K-RBP [<xref rid="B22-viruses-16-01870" ref-type="bibr">22</xref>], RUNX3 [<xref rid="B23-viruses-16-01870" ref-type="bibr">23</xref>], etc., either facilitate or repress viral gene transcription. On the other hand, KSHV also deploys its own regulatory proteins, like LANA, vFLIP, RTA, and K-bZIP, and viral microRNAs, which are indispensable for either triggering lytic replication or regulating the viral latent&#x02013;lytic cycle transition [<xref rid="B10-viruses-16-01870" ref-type="bibr">10</xref>,<xref rid="B16-viruses-16-01870" ref-type="bibr">16</xref>,<xref rid="B24-viruses-16-01870" ref-type="bibr">24</xref>,<xref rid="B25-viruses-16-01870" ref-type="bibr">25</xref>,<xref rid="B26-viruses-16-01870" ref-type="bibr">26</xref>,<xref rid="B27-viruses-16-01870" ref-type="bibr">27</xref>,<xref rid="B28-viruses-16-01870" ref-type="bibr">28</xref>,<xref rid="B29-viruses-16-01870" ref-type="bibr">29</xref>]. These interactions highlight a complex network of regulatory mechanisms that determine KSHV&#x02019;s ability to persist and replicate within host cells, ultimately impacting pathogenesis and disease progression associated with this oncogenic virus. Understanding these factors is crucial for developing targeted therapies against KSHV-related diseases. This review will introduce the epigenetic regulation involved in KSHV infection, including DNA methylation, histone modifications, post-translational modifications, chromatin remodeling, genome conformation, and non-coding RNAs. In addition, this review will discuss the roles of both viral and host factors in regulating KSHV transcription.</p></sec><sec id="sec2-viruses-16-01870"><title>2. Epigenetic Regulation in KSHV Infection</title><p>Epigenetic modifications can alter gene expression but do not change the underlying DNA sequence. These epigenetic modifications include DNA methylation, histone modifications, post-translational modifications, chromatin remodeling, genome conformation, and non-coding RNA expression. During viral infection, the viral genome undergoes epigenetic modifications that shape the transcriptional regulation of viral genes during both latency and lytic replication. These modifications also play a crucial role in the progression of their associated tumorigenesis. The chromatin landscape of the KSHV genome and the regulatory mechanisms by which viral proteins and host factors influence its activity through DNA methylation and histone modifications is summarized in <xref rid="viruses-16-01870-f001" ref-type="fig">Figure 1</xref>.</p><sec id="sec2dot1-viruses-16-01870"><title>2.1. DNA Methylation and KSHV Infection</title><p>DNA methylation is a key player in the epigenetic regulation of eukaryotes. It tends to methylate cytosines throughout the majority of genomic DNA, with unmethylated cytosines predominantly found in specific regions known as CpG islands [<xref rid="B30-viruses-16-01870" ref-type="bibr">30</xref>]. While most of the genome is CpG poor, some promoters contain high CpG content and are termed CpG islands. CpG islands control the expression of many housekeeping genes and are kept unmethylated in normal cells. However, in cancer cells, CpG islands often undergo methylation, altering their regulation patterns. Depending on the underlying gene sequence, DNA methylation in different genomic regions may exert different influences on gene activities. Generally, promoter methylation inhibits gene transcription, while gene body methylation induces gene transactivation [<xref rid="B31-viruses-16-01870" ref-type="bibr">31</xref>]. DNA methylation is added and maintained by several DNA methyltransferases (DNMTs): DNMT1, DNMT3A, and DNMT3B. Several DNMTs are known to modulate the methylation of the KSHV genome. DNMT3A can interact with LANA and is recruited to chromatin, facilitating cadherin-13 promoter methylation and its downregulation, thus promoting the progression of Kaposi&#x02019;s sarcoma [<xref rid="B32-viruses-16-01870" ref-type="bibr">32</xref>] (<xref rid="viruses-16-01870-f001" ref-type="fig">Figure 1</xref>B). LANA also binds to the promoter of the transforming growth factor &#x003b2; (TGF-&#x003b2;) type II receptor and inhibit its expression by inducing DNA methylation [<xref rid="B33-viruses-16-01870" ref-type="bibr">33</xref>] (<xref rid="viruses-16-01870-f001" ref-type="fig">Figure 1</xref>B). DNMT1 is upregulated by KSHV-encoded vIL-6 and increases the global genomic DNA methylation, thereby promoting cell proliferation and migration [<xref rid="B34-viruses-16-01870" ref-type="bibr">34</xref>] (<xref rid="viruses-16-01870-f001" ref-type="fig">Figure 1</xref>B). Under hypoxic conditions, KSHV-encoded vGPCR interacts with hypoxia-inducible factor 1 alpha (HIF1&#x003b1;) and induces the production of reactive oxygen species, which in turn modulates the expression of DNMT3A and DNMT3B [<xref rid="B35-viruses-16-01870" ref-type="bibr">35</xref>] (<xref rid="viruses-16-01870-f001" ref-type="fig">Figure 1</xref>B). In addition to viral proteins, KSHV-encoded microRNAs also regulate the expression of DNMTs. miR-K12-4-5p targets Rb12, which in turn increases the levels of DNMT3a, DNMT1, and DNMT3b and leads to CpG methylation of the KSHV episome [<xref rid="B36-viruses-16-01870" ref-type="bibr">36</xref>] (<xref rid="viruses-16-01870-f001" ref-type="fig">Figure 1</xref>B).</p><p>Hijacking DNA methylation by KSHV is likely a mechanism by which the virus maintains latent infection. It has been shown that 5-azacytidine, a DNA methyltransferase inhibitor, can activate KSHV to enter lytic replication [<xref rid="B12-viruses-16-01870" ref-type="bibr">12</xref>]. This finding highlights the importance of gene transcription de-repression as a key factor in initiating lytic replication. During latency, the promoter region of KSHV-RTA experiences extensive methylation. Demethylation of this region can boost RTA expression [<xref rid="B12-viruses-16-01870" ref-type="bibr">12</xref>]. Additionally, an analysis of genome-wide methylation patterns in KSHV revealed widespread DNA methylation across the latent KSHV genome, with the exception of the latency-associated sites [<xref rid="B37-viruses-16-01870" ref-type="bibr">37</xref>,<xref rid="B38-viruses-16-01870" ref-type="bibr">38</xref>]. Subsequent CpG methylation analysis of KS tissues revealed widespread global methylation alterations in KS. Hypermethylation occurs in the early stages of KS, while hypomethylation occurs in the later stages. The dramatic changes between hypermethylation and hypomethylation on gene promoters and enhancers play a significant role in the regulation of abnormal skin morphology and tumorigenesis [<xref rid="B39-viruses-16-01870" ref-type="bibr">39</xref>,<xref rid="B40-viruses-16-01870" ref-type="bibr">40</xref>].</p></sec><sec id="sec2dot2-viruses-16-01870"><title>2.2. Histone Modifications and KSHV Infection</title><p>It has been shown that DNA methylation occurs later than histone modifications during KSHV latency [<xref rid="B37-viruses-16-01870" ref-type="bibr">37</xref>]. Histones are core components of chromatin and undergo extensive modifications by diverse histone-targeting enzymes. These post-translational modifications exert significant influence on the accessibility of transcription factors and thus play a crucial role in regulating chromatin structure and gene expression. Histone modifications include methylation, acetylation, phosphorylation, ubiquitination, citrullination, etc. [<xref rid="B41-viruses-16-01870" ref-type="bibr">41</xref>].</p><sec id="sec2dot2dot1-viruses-16-01870"><title>2.2.1. Histone Methylation in KSHV Infection</title><p>In virions, the KSHV genome is histone-free [<xref rid="B42-viruses-16-01870" ref-type="bibr">42</xref>,<xref rid="B43-viruses-16-01870" ref-type="bibr">43</xref>]. However, once latency is established or following de novo infection, the viral genome rapidly acquires histone associations. A comprehensive genome-wide ChIP-on-Chip analysis of chromatin associated with the KSHV genome has shown that both activating and repressive histone marks colocalize on the latent genome [<xref rid="B44-viruses-16-01870" ref-type="bibr">44</xref>]. During latency, the genomic regions encoding RTA and ORF48 present a distinctive chromatin landscape with the H3K4me3 mark, reflecting transcription activity and the H3K27me3 mark associated with transcription repression. This form of chromatin that harbors both activating and repressive histone marks is known as bivalent chromatin [<xref rid="B45-viruses-16-01870" ref-type="bibr">45</xref>], and it provides the virus the ability to rapidly shift from repressed to activated promoter. Upon reactivation, there is a rapid increase in AcH3 and H3K4me3 marks and a decrease in the H3K27me3 mark. Notably, the presence of EZH2, a core component of the polycomb group protein complexes (PcG), has been implicated in the epigenetic regulation of KSHV. During latency, EZH2 binds to the KSHV genome, and colocalizes with the H3K27me3 mark. Upon reactivation, EZH2 dissociates from the viral genome, leading to a reduction in H3K27me3 levels, consequently triggering the initiation of lytic replication [<xref rid="B44-viruses-16-01870" ref-type="bibr">44</xref>]. During de novo infection, biphasic chromatinization has been observed on the KSHV genome. Initially, the KSHV genome exhibited high levels of H3K4me3 and H3K27ac, accompanied by a transient activation of a limited number of lytic genes [<xref rid="B46-viruses-16-01870" ref-type="bibr">46</xref>]. This phase was followed by a reduction in these activating marks and a shift toward an enrichment of repressive marks, particularly H3K27me3 and H2AK119ub [<xref rid="B46-viruses-16-01870" ref-type="bibr">46</xref>]. This transition from euchromatin to heterochromatin has been found to depend on both polycomb repressive complex 1 and 2 (PRC1 and PRC2) [<xref rid="B46-viruses-16-01870" ref-type="bibr">46</xref>].</p><p>KSHV-encoded LANA protein is essential for recruiting PRC1 and PRC2 to the KSHV genome following de novo infection, thus suppressing lytic gene expression [<xref rid="B47-viruses-16-01870" ref-type="bibr">47</xref>]. In addition to its interactions with PRCs, LANA can also recruit specific methyltransferases and demethylases to the KSHV genome. Studies suggest that LANA interacts with and recruits the H3K4me3 methyltransferase hSET1 and the H3K9me1/2 demethylase KDM3A, contributing to the regulation of chromatin modifications on the KSHV genome [<xref rid="B48-viruses-16-01870" ref-type="bibr">48</xref>,<xref rid="B49-viruses-16-01870" ref-type="bibr">49</xref>]. This recruitment results in the deposition of H3K4me3 on the KSHV genome and the removal of H3K9 methylation from the KSHV genome, allowing LANA to bind more tightly on the KSHV genome [<xref rid="B49-viruses-16-01870" ref-type="bibr">49</xref>]. LANA also recruits and interacts with histone methyltransferase SUV39H1 and heterochromatin protein 1, which facilitate the methylation of H3K9 on K1 and RTA [<xref rid="B50-viruses-16-01870" ref-type="bibr">50</xref>]. This process promotes the establishment of latent infection. In addition to LANA, cellular factors may also be helpful to the recruitment of PRCs to the KSHV genome. For instance, the PRC component KDM2B directly binds to CpG islands, further facilitating the maintenance of KSHV latency [<xref rid="B51-viruses-16-01870" ref-type="bibr">51</xref>,<xref rid="B52-viruses-16-01870" ref-type="bibr">52</xref>].</p><p>Besides the methylation of lysine residues on histone H3, arginine methylation of histone H4 also plays a crucial role in regulating chromatin compactness. It has been suggested that the KSHV-encoded ORF59 interacts with protein arginine methyltransferase 5 (PRMT5), disrupting its association with COPR5 (cooperator of PRMT5). PRMT5 is responsible for the symmetric dimethylation of arginine 3 (R3) on histone H4. This disruption reduces the methylation of H4R3 mediated by PRMT5 and COPR5 while increasing the trimethylation of H3K4 (H3K4me3), thereby promoting the establishment of an open chromatin structure [<xref rid="B53-viruses-16-01870" ref-type="bibr">53</xref>]. Additionally, ORF59 also interacts with KSHV long non-coding polyadenylated nuclear RNA (PAN RNA), which in turn associates with the cellular H3K27me3 demethylases UTX and JMJD3, effectively removing the repressive marks on the chromatin [<xref rid="B54-viruses-16-01870" ref-type="bibr">54</xref>].</p></sec><sec id="sec2dot2dot2-viruses-16-01870"><title>2.2.2. Histone Acetylation in KSHV Infection</title><p>Acetylation and deacetylation play vital roles in regulating gene expression in eukaryotic cells. Histone acetylation is commonly associated with the activation of gene expression, whereas histone deacetylation is linked to transcriptional silencing. This dynamic regulation involves crucial enzymes, namely histone acetyltransferases (HATs) and histone deacetylases (HDACs). Studies have shown that various inhibitors of HDACs are effective in reactivating KSHV from latency. Sodium butyrate (NaB) and trichostatin A (TSA) are two well-known inhibitors of class I and class II HDACs. NaB promotes histone hyperacetylation, leading to significant chromatin remodeling at the KSHV RTA promoter, which enhances RTA expression and promotes KSHV reactivation. Furthermore, NaB also facilitates the rapid dissociation of LANA from the RTA promoter, thereby disrupting the interactions between LANA and cellular proteins Sp1 and histone H2B [<xref rid="B55-viruses-16-01870" ref-type="bibr">55</xref>,<xref rid="B56-viruses-16-01870" ref-type="bibr">56</xref>]. SIRT1 is a member of class III HDAC sirtuins (SIRTs) that preferentially deacetylates histone H3 at lysines 9 and 14 (H3K9 and H3K14) and histone H4 at lysine 16 (H4K16), leading to chromatin condensation and transcriptional repression [<xref rid="B57-viruses-16-01870" ref-type="bibr">57</xref>]. During KSHV infection, SIRT1 can bind to the RTA promoter and inhibit RTA transactivation of its own promoter, preventing the expression of its downstream genes [<xref rid="B58-viruses-16-01870" ref-type="bibr">58</xref>].</p></sec></sec><sec id="sec2dot3-viruses-16-01870"><title>2.3. Post-Translational Modifications in KSHV Infection</title><sec id="sec2dot3dot1-viruses-16-01870"><title>2.3.1. SUMOylation and KSHV Infection</title><p>Small ubiquitin-like modifier (SUMO) modification is one of the most well-characterized post-translational modifications, playing a crucial role in regulating various biological processes. In 2003, it was demonstrated that SUMO modification is associated with transcriptional repression, as core histone H4 undergoes SUMOylation both in vivo and in vitro. This SUMO-induced transcriptional repression depends on the recruitment of histone deacetylases and heterochromatin protein 1 (HP1) [<xref rid="B59-viruses-16-01870" ref-type="bibr">59</xref>]. During KSHV infection, the viral protein KSHV basic leucine zipper (K-bZIP) promotes the SUMOylation of the histone demethylase Jumonji C (JmjC) domain-containing histone demethylase 2A (JMJD2A) in a SUMO-interacting motif (SIM)-dependent manner. This modification is crucial for JMJD2A&#x02019;s binding to viral chromatin and plays a significant role in the transactivation of viral genes during KSHV reactivation [<xref rid="B60-viruses-16-01870" ref-type="bibr">60</xref>]. In addition, SUMO is crucial for regulating the assembly and disassembly of PML-NBs or nuclear domain-10 (ND-10). PML-NBs serve as a vital component of the intrinsic antiviral defense by suppressing viral transcription and replication [<xref rid="B61-viruses-16-01870" ref-type="bibr">61</xref>]. RTA is a SUMO-targeting ubiquitin-ligase (STUbL), capable of binding to SUMOs and mediating the degradation of PML, which in turn impairs the formation of PML-NBs [<xref rid="B62-viruses-16-01870" ref-type="bibr">62</xref>]. Besides K-bZIP, LANA possesses two SUMO-interacting motifs (SIMs) that specifically bind to SUMO-2. This interaction enhances the SUMOylation of LANA. The SIMs in LANA recruit SUMO-modified chromatin remodeling proteins, such as Kr&#x000fc;ppel -associated box domain-associated protein-1 (KAP-1), leading to the silence of viral gene expression [<xref rid="B20-viruses-16-01870" ref-type="bibr">20</xref>,<xref rid="B63-viruses-16-01870" ref-type="bibr">63</xref>].</p></sec><sec id="sec2dot3dot2-viruses-16-01870"><title>2.3.2. Phosphorylation and KSHV Infection</title><p>Phosphorylation, a crucial post-translational modification, is activated by kinases or regulatory proteins and plays a fundamental role in regulating numerous physiological functions in eukaryotic cells. Viral protein kinase (vPK), encoded by KSHV ORF36, is a conserved serine protein kinase that induces both autophosphorylation and the phosphorylation of viral and cellular proteins. vPK can interact with and phosphorylate KSHV K-bZIP. This phosphorylation leads to a reduction in the SUMOylation levels and trans-repression activity of K-bZIP [<xref rid="B64-viruses-16-01870" ref-type="bibr">64</xref>]. Moreover, vPK also induces the phosphorylation of KAP-1 and reduces KAP-1 SUMOylation, which in turn decreases the binding ability of KAP-1 on chromatin [<xref rid="B65-viruses-16-01870" ref-type="bibr">65</xref>]. H<sub>2</sub>AX, an isoform of histone H<sub>2</sub>A, is significantly upregulated during KSHV infection. The phosphorylated form of H<sub>2</sub>AX interacts with LANA and plays a critical role in maintaining viral latency [<xref rid="B66-viruses-16-01870" ref-type="bibr">66</xref>].</p></sec></sec><sec id="sec2dot4-viruses-16-01870"><title>2.4. Chromatin Remodeling and KSHV Infection</title><p>Not only do histone modifications regulate gene transcription and expression, but chromatin remodelers do as well. Eukaryotic cells contain four families of chromatin remodelers, including swith/sucrose non-fermentable (SWI/SNF), imitation swith (ISWI), chromodomain helicase DNA-binding (CHD), and INOsitol requiring 80 (INO80). RTA, the transcription activator of KSHV, acts as a molecular switch for lytic reactivation that interacts with BRG1, a subunit of the SWI/SNF complex, and recruits the SWI/SNF complex to the promoter region to promote KSHV lytic reactivation [<xref rid="B67-viruses-16-01870" ref-type="bibr">67</xref>,<xref rid="B68-viruses-16-01870" ref-type="bibr">68</xref>]. In KSHV infected cells, NaB initiates KSHV reactivation. Mechanistically, NaB causes a significant increase in the association of Ini1/Snf5 with RTA and deregulates promoter-associated nucleosome [<xref rid="B56-viruses-16-01870" ref-type="bibr">56</xref>]. In addition to RTA, K8 interacts and colocalizes with another chromatin-remodeling factor hSNF5 and promotes its transactivation activity [<xref rid="B69-viruses-16-01870" ref-type="bibr">69</xref>].</p></sec><sec id="sec2dot5-viruses-16-01870"><title>2.5. Genome Conformation and KSHV Infection</title><p>KSHV genomic DNA is large and must exist within cells in a highly organized, folded state. This folding does not happen randomly but is well controlled by the structural maintenance of chromosomes (SMC) protein complexes. SMC protein complexes comprise cohesin, condensin and the SMC5/6 complex [<xref rid="B70-viruses-16-01870" ref-type="bibr">70</xref>]. Cohesins mediate sister chromatin cohesion and CTCF (CCCTC-binding factor), and function at chromatin boundaries, playing key roles in the structural and functional organization of chromosomes [<xref rid="B71-viruses-16-01870" ref-type="bibr">71</xref>]. During KSHV infection, CTCF and the cohesion complex associate at several regions on the KSHV genome, especially upstream of the major latency-associated transcript region [<xref rid="B72-viruses-16-01870" ref-type="bibr">72</xref>]. CTCF and cohesion primarily facilitate the formation of two major chromatin loops in the KSHV episome. The first is a short 10 kb loop connecting a cluster of three CTCF sites upstream of the LANA ORF to the 3&#x02032; end of the K12 gene. The second is a larger loop (&#x0003e;50 kb), linking the CTCF binding site cluster to the promoter for RTA [<xref rid="B73-viruses-16-01870" ref-type="bibr">73</xref>,<xref rid="B74-viruses-16-01870" ref-type="bibr">74</xref>]. It has been suggested that the disruption of CTCF&#x02013;cohesin binding eliminates the chromatin loops and reduces the expression of IE genes and increases LANA expression [<xref rid="B74-viruses-16-01870" ref-type="bibr">74</xref>]. In addition, the knockdown of cohesion subunits Rad21, SMC1, and SMC3 promotes KSHV lytic gene transcription and viral DNA replication [<xref rid="B75-viruses-16-01870" ref-type="bibr">75</xref>,<xref rid="B76-viruses-16-01870" ref-type="bibr">76</xref>]. It is important to note that CTCF binding is sensitive to methylation at its binding site [<xref rid="B77-viruses-16-01870" ref-type="bibr">77</xref>]. Therefore, DNA methylation on the KSHV genome is also expected to regulate CTCF binding and episome chromatin loops. These findings suggest that CTCF and cohesin are important for regulating latent and lytic viral gene expression. In addition to cohesin and CTCF, the SMC5/6 complex also plays an important role in regulating KSHV gene expression. The SMC5/6 complex can bind to the KSHV episome and suppress KSHV gene transcription by condensing the viral chromatin and creating a repressive chromatin structure [<xref rid="B78-viruses-16-01870" ref-type="bibr">78</xref>].</p></sec><sec id="sec2dot6-viruses-16-01870"><title>2.6. Non-Coding RNAs</title><p>Non-coding RNAs (ncRNAs) encompass a group of RNAs that do not encode functional proteins and can be categorized into two main types: housekeeping ncRNAs and regulatory ncRNAs. Regulatory ncRNAs play a crucial role in epigenetic regulation and can be further grouped into two subclasses based on transcript size: small non-coding RNAs (20&#x02013;200 nucleotides) and long non-coding RNAs (lncRNAs, over 200 nucleotides) [<xref rid="B79-viruses-16-01870" ref-type="bibr">79</xref>]. Polyadenylated nuclear RNA (PAN RNA) is a viral lncRNA encoded by KSHV that significantly influences KSHV gene expression, replication, and immune modulation [<xref rid="B80-viruses-16-01870" ref-type="bibr">80</xref>]. During the KSHV life cycle, PAN RNA is vital for the production of progeny virions and the expression of various lytic genes. Notably, a recombinant BACmid that deletes most of the PAN RNA locus fails to produce infectious viral particles and leads to the downregulation of the expression of RTA and other viral genes. Mechanistically, PAN RNA interacts with cellular H3K27me3 demethylases JMJD3 and UTX, erasing repressive marks on the KSHV genome and regulating viral gene expression [<xref rid="B81-viruses-16-01870" ref-type="bibr">81</xref>]. In addition, PAN RNA enhances the interaction between ORF59 and JMJD3/UTX, further facilitating histone demethylation and promoting gene expression [<xref rid="B54-viruses-16-01870" ref-type="bibr">54</xref>]. N4-acetylcytidine (ac4C) is a novel mRNA modification catalyzed by N-acetyltransferase 10 (NAT10) [<xref rid="B82-viruses-16-01870" ref-type="bibr">82</xref>]. It has been suggested that NAT10 catalyzes ac4C addition to PAN RNA and triggers viral lytic reactivation from latency [<xref rid="B83-viruses-16-01870" ref-type="bibr">83</xref>]. Mechanistically, PAN coordinates NAT10 and ATAT1 to enhance NAT10 lactylation, promoting the ac4C modification of tRNA Ser-CGA-1-1, and eventually it facilitates KSHV reactivation [<xref rid="B84-viruses-16-01870" ref-type="bibr">84</xref>]. Another way PAN RNA may promote viral lytic reactivation is via the sequestration of LANA away from the KSHV episomes during reactivation [<xref rid="B85-viruses-16-01870" ref-type="bibr">85</xref>].</p><p>MicroRNAs are a group of non-coding, small, single-stranded RNAs that inhibit gene expression by binding to the complementary regions of target genes, typically within the 3&#x02032; untranslated region (3&#x02032;UTR). KSHV encodes 12 pre-microRNAs (pre-miRNAs) that are processed into 25 mature microRNAs (miRNAs) [<xref rid="B86-viruses-16-01870" ref-type="bibr">86</xref>,<xref rid="B87-viruses-16-01870" ref-type="bibr">87</xref>]. These microRNAs are located at the latent locus in the KSHV genome and are expressed during the viral latent phase [<xref rid="B87-viruses-16-01870" ref-type="bibr">87</xref>]. Notably, some viral miRNAs can also present in viral particles and be transported into host cells [<xref rid="B88-viruses-16-01870" ref-type="bibr">88</xref>]. These microRNAs are essential for regulating various important processes throughout the KSHV life cycle by directly targeting viral genes or indirectly influencing host cellular genes. Key processes modulated by these microRNAs include the maintenance of viral latency, the evasion of immune responses, and the regulation of cell proliferation and apoptosis [<xref rid="B29-viruses-16-01870" ref-type="bibr">29</xref>]. For instance, miR-K9, miR-K7, and miR-K12-7-5p have been identified as direct regulators of RTA, suppressing its expression and helping KSHV in sustaining latent infection [<xref rid="B36-viruses-16-01870" ref-type="bibr">36</xref>,<xref rid="B89-viruses-16-01870" ref-type="bibr">89</xref>,<xref rid="B90-viruses-16-01870" ref-type="bibr">90</xref>]. In addition to their direct effects on viral genes, various microRNAs also impact KSHV gene expression through modulation of specific cellular factors. MiR-K11, for example, regulates the transcription factor MYB, while miR-K3 influences the activity of nuclear factor I/B, both of which indirectly contribute to the suppression of RTA expression [<xref rid="B91-viruses-16-01870" ref-type="bibr">91</xref>,<xref rid="B92-viruses-16-01870" ref-type="bibr">92</xref>]. Furthermore, microRNAs can affect the methylation status of the RTA promoter. MiR-K4-5p inhibits the expression of retinoblastoma-like protein 2 (Rbl2), resulting in the upregulation of DNA methyltransferases 1, 3a, and 3b, promoting the methylation of the RTA promoter and facilitating the maintenance of latency in host cells [<xref rid="B36-viruses-16-01870" ref-type="bibr">36</xref>]. SMAD5, an important mediator in TGF-&#x003b2; signaling, is downregulated by miR-K12-11 during KSHV de novo infection. The direct association between miR-K12-11 and SMAD5 inhibits cell proliferation [<xref rid="B93-viruses-16-01870" ref-type="bibr">93</xref>]. Furthermore, it has been suggested that miRNAs such as miR-K5, miR-K9, and miR-K10 can trigger KSHV reactivation by repressing Bcl-2-associated transcription factor 1, which in turn inhibits apoptosis [<xref rid="B94-viruses-16-01870" ref-type="bibr">94</xref>]. In addition to apoptosis, interferon (IFN) signaling is also important for medicating antiviral innate immunity. The ectopic expression of miR-K12-11 decreases I-kappa-B kinase epsilon (IKK&#x003b5;) expression, further inhibiting KSHV reactivation [<xref rid="B95-viruses-16-01870" ref-type="bibr">95</xref>]. In summary, these KSHV-encoded microRNAs are crucial regulators of both KSHV latency and lytic replication, significantly influencing the virus&#x02019;s ability to persist and propagate within host cells.</p></sec></sec><sec id="sec3-viruses-16-01870"><title>3. Transcriptional Regulation in KSHV Infection</title><p>Transcriptional control is an essential part of KSHV infection, governing the viral life cycle and impacting host interactions. Differences in gene expression between the latent and lytic phases of KSHV are critical to its capacity to maintain latency while sustaining lytic replication and pathogenicity. During latency, KSHV maintains its genome as an episome and only expresses limited viral transcripts encoded within the latency-associated gene cluster that facilitate persistence and immune evasion [<xref rid="B9-viruses-16-01870" ref-type="bibr">9</xref>]. Among them, LANA as a functional viral protein is essential for the transcription of latent genes by binding to both viral and host promoters [<xref rid="B96-viruses-16-01870" ref-type="bibr">96</xref>]. Additionally, host proteins such as Oct-1 [<xref rid="B18-viruses-16-01870" ref-type="bibr">18</xref>] and Sp1 [<xref rid="B97-viruses-16-01870" ref-type="bibr">97</xref>] can further facilitate the transcription of latency-associated genes, contributing to viral persistence. Upon reactivation, KSHV initiates a lytic phase defined by the expression of numerous lytic genes critical for viral replication and generation. The temporal gene expression program of KSHV during the lytic phase is a tightly regulated process that involves the sequential activation of immediate-early genes, early genes, and late genes [<xref rid="B98-viruses-16-01870" ref-type="bibr">98</xref>,<xref rid="B99-viruses-16-01870" ref-type="bibr">99</xref>]. The transcriptional regulation of KSHV entails a sophisticated and dynamic interplay between viral and host factors, underscoring the complexity of this process. The transcriptional regulation of KSHV is a multifaceted and dynamic process that relies on both viral and host factors. The delicate interplay is summarized in <xref rid="viruses-16-01870-f002" ref-type="fig">Figure 2</xref>.</p><sec id="sec3dot1-viruses-16-01870"><title>3.1. Function of KSHV-Encoded Transcriptional Regulators</title><p>KSHV, a sophisticated virus, expresses around 90 proteins in an orchestrated temporal sequence across its replication cycle. This virus encodes an array of viral transcription factors crucial for governing its life cycle, particularly in modulating gene expression during both latency and lytic replication [<xref rid="B100-viruses-16-01870" ref-type="bibr">100</xref>].</p><sec id="sec3dot1dot1-viruses-16-01870"><title>3.1.1. LANA</title><p>LANA serves as a critical transcriptional regulator for KSHV by modulating the transcription of viral genes in several ways. Firstly, LANA can mediate transcriptional suppression and activation by direct DNA binding. In the presence of LANA, LANA binding sites 1 and 2 (LBS1 and LBS2) can repress transcription from an artificial minimal promoter when positioned upstream [<xref rid="B101-viruses-16-01870" ref-type="bibr">101</xref>,<xref rid="B102-viruses-16-01870" ref-type="bibr">102</xref>]. LANA binds to the promoters of latency-associated genes, facilitating their transcription while repressing RTA transcription and concurrently suppressing RTA expression, thereby contributing to the maintenance of KSHV in a latent state. It can directly repress transcription from the ORF50 promoter or indirectly repress it by competitively binding with co-factors CBP and the Notch pathway effector recombination signal-binding protein (RBP-J&#x003ba;), thereby preventing RTA-mediated auto-activation [<xref rid="B24-viruses-16-01870" ref-type="bibr">24</xref>,<xref rid="B25-viruses-16-01870" ref-type="bibr">25</xref>,<xref rid="B103-viruses-16-01870" ref-type="bibr">103</xref>]. LANA can repress transcription of the K1 promoter by interacting with LBS1 and LBS2 in the transcriptional regulatory areas of the viral genome [<xref rid="B104-viruses-16-01870" ref-type="bibr">104</xref>]. Beyond its specific DNA-binding capability, LANA functions as a versatile transcriptional co-factor on various promoters, regardless of the presence of its unique DNA-binding recognition motif. LANA can transactivate the human telomerase reverse transcriptase (hTERT) promoter by interacting with the cellular transcription factor Sp1. In addition, this is also achieved through interactions with a range of cellular proteins, including: RBP-J&#x003ba; [<xref rid="B24-viruses-16-01870" ref-type="bibr">24</xref>], p53 [<xref rid="B105-viruses-16-01870" ref-type="bibr">105</xref>], Rb [<xref rid="B106-viruses-16-01870" ref-type="bibr">106</xref>], GSK-3&#x003b2; [<xref rid="B107-viruses-16-01870" ref-type="bibr">107</xref>], CBP [<xref rid="B108-viruses-16-01870" ref-type="bibr">108</xref>,<xref rid="B109-viruses-16-01870" ref-type="bibr">109</xref>], ATF4/CREB2, Ring3, KSHV RTA [<xref rid="B103-viruses-16-01870" ref-type="bibr">103</xref>].</p><p>In the context of KSHV infection, LANA plays a pivotal role in the transcriptional regulation of its own promoter. Even in the absence of other viral proteins, the LANA promoter (LANAp) remains active. However, when LANA is expressed, it further enhances the activity of its own promoter, establishing a positive-feedback mechanism [<xref rid="B26-viruses-16-01870" ref-type="bibr">26</xref>,<xref rid="B110-viruses-16-01870" ref-type="bibr">110</xref>,<xref rid="B111-viruses-16-01870" ref-type="bibr">111</xref>]. This auto-activation not only sustains LANA&#x02019;s expression but also contributes to the control of viral genome copy number and the expression of other viral genes [<xref rid="B111-viruses-16-01870" ref-type="bibr">111</xref>]. Beyond its impact on the viral genome, LANA interacts with a variety of host transcription factors and chromatin-modifying proteins, thereby influencing the expression of host genes. It upregulates the expression of numerous cellular genes, including CDKN1A, CDK4, HDAC1, MCL1, BAP1, TNFRSF10B, and CDKN2A, JUN, and so on [<xref rid="B112-viruses-16-01870" ref-type="bibr">112</xref>]. Recently, our group found that LANA upregulates PRMT5 in KSHV latently infected cells through transcriptional activation [<xref rid="B113-viruses-16-01870" ref-type="bibr">113</xref>]. These interactions suggest that LANA has a broad role in modulating the host cellular environment to support viral persistence. Conversely, LANA also exerts inhibitory effects on certain host genes, such as the TGF&#x003b2;-II receptor (T&#x003b2;RII) and TNF, modestly [<xref rid="B33-viruses-16-01870" ref-type="bibr">33</xref>]. Our previous study also shown that LANA represses the expression of SUMO-specific peptidase 6 (SENP6), an enzyme responsible for protein desumoylation, thus promoting its own sumoylation and stability. This repression is crucial for maintaining KSHV latency, as sumoylation of LANA enhances its regulatory roles in episome maintenance and suppression of viral reactivation [<xref rid="B114-viruses-16-01870" ref-type="bibr">114</xref>]. This dual capacity to both activate and repress gene expression allows LANA to fine-tune the host-cellular landscape, potentially promoting viral latency.</p></sec><sec id="sec3dot1dot2-viruses-16-01870"><title>3.1.2. vFLIP</title><p>Other KSHV latency genes, in concert with LANA, collectively contribute to the maintenance of KSHV in a latent state [<xref rid="B115-viruses-16-01870" ref-type="bibr">115</xref>]. vFLIP and LANA collaborate to enhance the expression of enhancer of EZH2, the H3K27 methyltransferase component of the PRC2, by activating the NF-&#x003ba;B pathway [<xref rid="B116-viruses-16-01870" ref-type="bibr">116</xref>]. Also, vFLIP attenuates RTA-mediated transactivation by modulating the NF-&#x003ba;B pathway, which in turn affects the binding and recruitment of RBP-J&#x003ba; [<xref rid="B10-viruses-16-01870" ref-type="bibr">10</xref>,<xref rid="B16-viruses-16-01870" ref-type="bibr">16</xref>]. This mechanism competes with RTA for the same co-factor, thereby reducing RTA&#x02019;s ability to transactivate its target genes [<xref rid="B14-viruses-16-01870" ref-type="bibr">14</xref>]. Furthermore, vFLIP is known to inhibit the AP-1 pathway, which is essential for KSHV lytic replication. By suppressing the AP-1 pathway, vFLIP can repress the transcription of RTA and other downstream lytic genes, thereby maintaining the viral latency [<xref rid="B16-viruses-16-01870" ref-type="bibr">16</xref>]. This dual regulation of cellular pathways by vFLIP provides a means for KSHV to control its replication state and contribute to its ability to persist in a latent state within the host cell [<xref rid="B117-viruses-16-01870" ref-type="bibr">117</xref>].</p></sec><sec id="sec3dot1dot3-viruses-16-01870"><title>3.1.3. RTA</title><p>KSHV ORF50 encodes a critical protein known as the replication and transcription activator (RTA). This protein is unique in its ability to induce the shift from viral latency to the active lytic phase singlehandedly [<xref rid="B27-viruses-16-01870" ref-type="bibr">27</xref>,<xref rid="B118-viruses-16-01870" ref-type="bibr">118</xref>,<xref rid="B119-viruses-16-01870" ref-type="bibr">119</xref>]. Functioning as a transcriptional activator, RTA carries a DNA-binding domain that targets specific sequences on the DNA, along with a transactivation domain that boosts the transcription of genetic information [<xref rid="B120-viruses-16-01870" ref-type="bibr">120</xref>]. The activation of RTA sets off a chain reaction that leads to the expression of other lytic genes, thereby orchestrating the viral replication process. This makes RTA not only a key player but also a central point of control in the transcriptional regulation of KSHV. Accumulation of RTA to a threshold level enables it to displace LANA from RBP-J&#x003ba;, its principal co-factor, thereby enabling RTA to bind to 100 specific sites within the viral genome [<xref rid="B14-viruses-16-01870" ref-type="bibr">14</xref>,<xref rid="B121-viruses-16-01870" ref-type="bibr">121</xref>]. This binding capability enables RTA to activate the transcription of 34 lytic genes, which are essential for the viral replication cycle. Among the genes transactivated by RTA are K8, K5, K2, K12, K14, ORF6, ORF57, ORF74, K9, ORF59, K3, ORF37, K1, K8.1A, ORF21, vIL-6, PAN RNA, vIRF1, and ORF65, as well as the two lytic replication origins, OriLyt-L and OriLyt-R, and a cluster of microRNAs [<xref rid="B27-viruses-16-01870" ref-type="bibr">27</xref>,<xref rid="B86-viruses-16-01870" ref-type="bibr">86</xref>,<xref rid="B122-viruses-16-01870" ref-type="bibr">122</xref>,<xref rid="B123-viruses-16-01870" ref-type="bibr">123</xref>,<xref rid="B124-viruses-16-01870" ref-type="bibr">124</xref>]. RTA can achieve this regulation either directly, through RTA-responsive elements, or indirectly, by interacting with other viral or host regulatory factors, thereby orchestrating a comprehensive transcriptional program that drives the lytic phase of the viral life cycle [<xref rid="B122-viruses-16-01870" ref-type="bibr">122</xref>,<xref rid="B125-viruses-16-01870" ref-type="bibr">125</xref>,<xref rid="B126-viruses-16-01870" ref-type="bibr">126</xref>,<xref rid="B127-viruses-16-01870" ref-type="bibr">127</xref>].</p><p>Transcriptional regulation by RTA on downstream gene promoters is intricate and complex. Broadly speaking, the precision of RTA in targeting specific promoters is attributed to its dual mechanism of action, which can be either direct or indirect. Furthermore, the RTA&#x02019;s engagement with these promoters is flexible, operating independently or in conjunction with the cellular factor such as RBP-J&#x003ba; [<xref rid="B126-viruses-16-01870" ref-type="bibr">126</xref>]. Direct transcriptional activation is achieved through RTA binding to RTA-responsive elements (RREs) in certain promoters. RREs are specific DNA sequences that serve as binding sites for RTA, allowing it to directly activate the transcription of downstream lytic genes, effectively driving the virus from latency into a productive lytic state [<xref rid="B128-viruses-16-01870" ref-type="bibr">128</xref>,<xref rid="B129-viruses-16-01870" ref-type="bibr">129</xref>]. Several replication and transcription activator response elements (RREs) have been identified in the promoters of delayed-early viral genes (e.g., tk, ORF57/MTA, K8/RAP, K2, K9, K14, and DBP) and in one late promoter (gB) using a promoter&#x02013;reporter cotransfection assay. RTA also activates another set of target genes, PAN and K12, via a direct DNA-binding method. These genes feature RTA response elements in their promoter regions that are similar in sequence to those found in the viral lytic replication origin, oriLyt-L, which is situated between the ORFs K4.2 and K5 [<xref rid="B128-viruses-16-01870" ref-type="bibr">128</xref>]. Notably, RTA&#x02019;s interaction with the vIL-6 promoter, despite its ability to bind, shows little sequence resemblance to the conserved sequences present in the PAN and K12 promoters, suggesting a divergence in the mechanisms of RTA-mediated gene activation across different viral genes [<xref rid="B130-viruses-16-01870" ref-type="bibr">130</xref>]. The reason for the RTA&#x02019;s diverse DNA-binding specificities is unclear. Additionally, ORF50 induces the expression of numerous target genes via an indirect way. Among the various co-factors that work with RTA, the protein RBP-J&#x003ba; (also known as CSL), a crucial component of the Notch signaling pathway, is particularly essential. It plays an indispensable role in enabling RTA to activate transcription at both viral and cellular promoters and is vital for efficient viral reactivation. Typically, RBP-J&#x003ba; binds to DNA in promoter regions and functions as a repressor until activated by signaling cues. The interaction with RTA converts RBP-J&#x003ba; from a repressive to an activating state for target gene transcription. Such transactivation by the ORF50 protein has been documented for several promoters, including those of ORF57, ORF6, K14/ORF74, K6 (vMIP-1), ORF50, and LANA (LTi) [<xref rid="B24-viruses-16-01870" ref-type="bibr">24</xref>,<xref rid="B131-viruses-16-01870" ref-type="bibr">131</xref>,<xref rid="B132-viruses-16-01870" ref-type="bibr">132</xref>,<xref rid="B133-viruses-16-01870" ref-type="bibr">133</xref>,<xref rid="B134-viruses-16-01870" ref-type="bibr">134</xref>]. Furthermore, the RTA&#x02019;s action through protein&#x02013;protein interactions with RBP-J&#x003ba; suggests an indirect mechanism that may proceed independently of RTA&#x02019;s DNA-binding function yet is contingent upon the expression of RTA [<xref rid="B134-viruses-16-01870" ref-type="bibr">134</xref>]. Besides RBP-J&#x003ba;, other cellular proteins, such as C/EBP&#x003b2; [<xref rid="B135-viruses-16-01870" ref-type="bibr">135</xref>], OCT1 [<xref rid="B18-viruses-16-01870" ref-type="bibr">18</xref>], c-Jun [<xref rid="B136-viruses-16-01870" ref-type="bibr">136</xref>], Sp1 [<xref rid="B15-viruses-16-01870" ref-type="bibr">15</xref>], etc., have been shown to interact with ORF50-responsive promoters.</p><p>Moreover, RTA can auto-stimulate its own promoter, potentially amplifying subtle environmental signals to facilitate viral replication [<xref rid="B124-viruses-16-01870" ref-type="bibr">124</xref>]. Within the promoter region of RTA in KSHV, three principal sets of regulatory elements&#x02014;the Oct1, C/EBP, and RBP-J&#x003ba; binding sites&#x02014;are implicated in the autoregulatory control of RTA [<xref rid="B18-viruses-16-01870" ref-type="bibr">18</xref>,<xref rid="B132-viruses-16-01870" ref-type="bibr">132</xref>,<xref rid="B135-viruses-16-01870" ref-type="bibr">135</xref>]. Furthermore, six RBP-J binding sites are identified in the ORF50 promoter [<xref rid="B131-viruses-16-01870" ref-type="bibr">131</xref>,<xref rid="B132-viruses-16-01870" ref-type="bibr">132</xref>]. The interaction of RBP-J&#x003ba; with these sites is presumed to be essential for the autoregulatory control of RTA, suggesting a key mechanism by which the gene modulates its own transcriptional activity [<xref rid="B137-viruses-16-01870" ref-type="bibr">137</xref>]. RTA initiates a positive feedback loop by transactivating its own promoter, which surpasses latency and amplifies lytic gene expression. This loop is perpetuated by lytic gene products: the K8 protein stabilizes CEBP&#x003b1; to enhance RTA-mediated transactivation, while ORF57 binds to RTA, boosting transcription from the RTA promoter [<xref rid="B119-viruses-16-01870" ref-type="bibr">119</xref>,<xref rid="B135-viruses-16-01870" ref-type="bibr">135</xref>,<xref rid="B138-viruses-16-01870" ref-type="bibr">138</xref>]. Consequently, the interplay between lytic proteins sustains KSHV reactivation and propels the lytic cycle forward [<xref rid="B115-viruses-16-01870" ref-type="bibr">115</xref>]. RTA also positively regulates all KSHV lytic enhancers [<xref rid="B139-viruses-16-01870" ref-type="bibr">139</xref>]. RTA activates the terminal repeats (TR) enhancer, while LANA represses this enhancer to maintain the latency cycle.</p></sec><sec id="sec3dot1dot4-viruses-16-01870"><title>3.1.4. K-bZIP</title><p>The KSHV-encoded protein K-bZIP, derived from the K8 gene, exerts substantial influence over the regulation of viral gene expression. This protein also plays a crucial role in the virus&#x02019;s capacity to adjust the host cell&#x02019;s responses, thereby contributing to the intricate interplay between the virus and its host. In a screen of 83 potential KSHV promoter regions within 293 cells, the K-bZIP protein was found to independently activate 21 promoters. Additionally, it enhances the activation of 19 promoters in conjunction with RTA, while it also suppresses the RTA-mediated transactivation of 3 promoters [<xref rid="B140-viruses-16-01870" ref-type="bibr">140</xref>]. Direct protein&#x02013;protein interaction is attributed to the inhibition of RTA transactivation by K-bZIP; hence, the overexpression of transcriptional coactivators is not helpful to offset this inhibitory effect [<xref rid="B28-viruses-16-01870" ref-type="bibr">28</xref>].</p></sec></sec><sec id="sec3dot2-viruses-16-01870"><title>3.2. Function of Host Transcriptional Regulators</title><p>The host transcription factors that regulate KSHV gene expression include a diverse set of proteins. A number of cellular DNA-binding proteins, along with transcriptional co-factors and enzymes, have been demonstrated as essential for controlling the expression of both latent and lytic genes in KSHV. These proteins play a pivotal role in the virus&#x02019;s ability to switch between its dormant and active states, thereby influencing the viral life cycle and pathogenesis, including response element-binding protein (CREB) [<xref rid="B141-viruses-16-01870" ref-type="bibr">141</xref>], p53 [<xref rid="B142-viruses-16-01870" ref-type="bibr">142</xref>], CREB-binding protein and p300 (CBP/p300) [<xref rid="B141-viruses-16-01870" ref-type="bibr">141</xref>], RBP-J&#x003ba; [<xref rid="B134-viruses-16-01870" ref-type="bibr">134</xref>], CCAAT/enhancer-binding protein (C/EBP) [<xref rid="B119-viruses-16-01870" ref-type="bibr">119</xref>], interferon regulatory factor 7 (IRF7) [<xref rid="B143-viruses-16-01870" ref-type="bibr">143</xref>], specificity protein 1 (SP1) [<xref rid="B15-viruses-16-01870" ref-type="bibr">15</xref>], octamer-binding transcription factor 1 (OCT1) [<xref rid="B18-viruses-16-01870" ref-type="bibr">18</xref>], activator protein 1 complex (AP-1) [<xref rid="B16-viruses-16-01870" ref-type="bibr">16</xref>], NF-&#x003ba;B [<xref rid="B14-viruses-16-01870" ref-type="bibr">14</xref>], hypoxia-inducible factor 1-alpha (HIF-1&#x003b1;) [<xref rid="B144-viruses-16-01870" ref-type="bibr">144</xref>], c-Myc [<xref rid="B145-viruses-16-01870" ref-type="bibr">145</xref>], signal transducer and activator of transcription 3 (STAT3) [<xref rid="B17-viruses-16-01870" ref-type="bibr">17</xref>], GATA [<xref rid="B146-viruses-16-01870" ref-type="bibr">146</xref>], E2F [<xref rid="B106-viruses-16-01870" ref-type="bibr">106</xref>], RUNX3 [<xref rid="B23-viruses-16-01870" ref-type="bibr">23</xref>], cAMP [<xref rid="B109-viruses-16-01870" ref-type="bibr">109</xref>], histone deacetylase-1 (HDAC1) [<xref rid="B141-viruses-16-01870" ref-type="bibr">141</xref>], MGC2663 [<xref rid="B147-viruses-16-01870" ref-type="bibr">147</xref>], SWI/SNF complex, TRAP/mediator complex, poly(ADP-ribose) polymerase 1 (PARP-1) [<xref rid="B148-viruses-16-01870" ref-type="bibr">148</xref>], Ste20-like kinase (hKFC). As above mentioned, numerous host factors participate in the transcriptional modulation of KSHV. Below, we will emphasize some key host transcriptional regulators that operate during KSHV&#x02019;s latent and lytic stages.</p><p>LANA is essential for initiating KSHV latency, with its multifaceted roles relying on its capacity to recruit host factors to the viral genome. For example, LANA binds to both N- and C-terminal domains of KAP1, recruiting it to the RTA promoter and terminal repeat (TR) regions of the KSHV genome. This interaction leads to transcriptional repression of lytic genes, helping to establish and maintain viral latency [<xref rid="B20-viruses-16-01870" ref-type="bibr">20</xref>]. Moreover, LANA induces protease-mediated cleavage of STAT6, removing its transactivation domain and converting it into a transcriptional repressor of the RTA promoter [<xref rid="B149-viruses-16-01870" ref-type="bibr">149</xref>]. Another study proved that LANA interacts with and suppresses the activity of both Rb [<xref rid="B106-viruses-16-01870" ref-type="bibr">106</xref>] and p53 [<xref rid="B150-viruses-16-01870" ref-type="bibr">150</xref>] in experimental assays. Inversely, p53 has been shown to suppress the activity of the LANA promoter, indicating a reciprocal regulatory relationship between LANA and these cellular proteins [<xref rid="B111-viruses-16-01870" ref-type="bibr">111</xref>]. Notably, NF-&#x003ba;B also plays a key role in maintaining KSHV latency by preventing the expression of lytic genes. The viral protein vFLIP continuously activates NF-&#x003ba;B signaling to support this latent state [<xref rid="B151-viruses-16-01870" ref-type="bibr">151</xref>]. KSHV lytic action is competitively inhibited by activated NF-&#x003ba;B complexes with the RTA co-factor RBP-J&#x003ba; [<xref rid="B14-viruses-16-01870" ref-type="bibr">14</xref>]. However, NF-&#x003ba;B&#x02019;s function is complex, as it can also promote viral reactivation under specific conditions. This context-dependent regulation highlights the multifaceted role of NF-&#x003ba;B in KSHV infection. In the context of KSHV infection, STAT3 is also constitutively activated to modulate KSHV latency and lytic replication through influencing the expression of key viral genes. For example, STAT3 has been shown to interact with the KSHV genome, particularly with the regulation of the viral interleukin-6 (vIL-6) gene, which is crucial for viral replication and immune evasion. Furthermore, STAT3 has been found to repress the expression of RTA, and therefore it helps to maintain the virus in a latent state, preventing premature lytic replication and the associated cellular damage that could trigger an immune response [<xref rid="B152-viruses-16-01870" ref-type="bibr">152</xref>,<xref rid="B153-viruses-16-01870" ref-type="bibr">153</xref>]. Additionally, KSHV uses Sp1 binding sites on the promoters of latency genes, such as LANA, to maintain latency. Likewise, Sp1 contributes to the regulation of viral lytic genes during reactivation as well, thereby serving as a bridge between the latent and lytic phases. Our group&#x02019;s research has demonstrated that LANA interacts with KAP1 and directs it to the RTA promoter within the KSHV genome. This interaction plays a role in the suppression of lytic gene expression by LANA [<xref rid="B20-viruses-16-01870" ref-type="bibr">20</xref>]. A number of studies have indicated that LANA recruits multiple cellular transcription factors, including SP1 [<xref rid="B97-viruses-16-01870" ref-type="bibr">97</xref>], E2F, Ap1, RBP-J&#x003ba;, ATF4 [<xref rid="B108-viruses-16-01870" ref-type="bibr">108</xref>], CBP, Id-1 [<xref rid="B154-viruses-16-01870" ref-type="bibr">154</xref>], and nucleosome assembly protein (NAP1L1) [<xref rid="B155-viruses-16-01870" ref-type="bibr">155</xref>], and influences their regulation of viral gene expression. Additionally, the enzymes poly (ADP-ribose) polymerase 1 and Ste20-like kinase hKFC function as transcriptional repressors, controlling the lytic replication of gamma-2 herpesvirus [<xref rid="B148-viruses-16-01870" ref-type="bibr">148</xref>]. Furthermore, the activated form of Nrf2 collaborates with LANA and KAP1 to suppress the expression of lytic genes, indicating its role in maintaining KSHV latency [<xref rid="B156-viruses-16-01870" ref-type="bibr">156</xref>].</p><p>During KSHV latency, RBP-J&#x003ba; is associated with the repression of lytic gene expression. Upon activation signals, RBP-J&#x003ba; can dissociate from the repressive complexes, allowing for the transcription of lytic genes [<xref rid="B157-viruses-16-01870" ref-type="bibr">157</xref>,<xref rid="B158-viruses-16-01870" ref-type="bibr">158</xref>]. This switch is critical for the transition from latency to lytic replication. RBP-J&#x003ba; can also recruit co-activators such as CBP/p300 to KSHV promoters, which enhances transcriptional activity [<xref rid="B159-viruses-16-01870" ref-type="bibr">159</xref>]. Additionally, NF-&#x003ba;B acts as a key cellular regulator during KSHV infection, sensing viral latency and inhibiting the switch to the lytic phase. It achieves this by counteracting the activity of RTA. Specifically, NF-&#x003ba;B interferes with RTA&#x02019;s ability by antagonizing the function of RBP-J&#x003ba;, a coactivator required for RTA&#x02019;s transcriptional activity [<xref rid="B14-viruses-16-01870" ref-type="bibr">14</xref>]. In addition to RBP-J&#x003ba;, RTA also engages with C/EBP&#x003b2; and STAT3 to stimulate the activity of both viral and cellular promoter [<xref rid="B17-viruses-16-01870" ref-type="bibr">17</xref>]. Additionally, SIRT1 has been shown to physically associate with RTA, thereby inhibiting the activation of its own promoter as well as other lytic gene promoters. Similarly, SIRT6 binds to the KSHV ori-Lyt and ORF50 promoters, repressing viral replication by interacting directly with the KSHV genome and blocking viral gene expression [<xref rid="B115-viruses-16-01870" ref-type="bibr">115</xref>]. Several other proteins are involved in forming an active transcriptional complex with RTA&#x02019;s C-terminal transactivation domain. These include the CBP histone acetyltransferase, the BRG1 component of the SWI/SNF chromatin remodeling complex, and the TRAP230 subunit of the TRAP/mediator complex, which may be crucial for RTA-mediated transcriptional activation [<xref rid="B67-viruses-16-01870" ref-type="bibr">67</xref>,<xref rid="B141-viruses-16-01870" ref-type="bibr">141</xref>]. Protein kinase C (PKC) delta isoform activates the MAPK/ERK pathway upon treatment with inducers such as TPA, which in turn leads to the phosphorylation of c-Jun and accumulation of c-Fos. This activation forms an active AP-1 complex, which is crucial for initiating the transcription of the KSHV RTA gene and subsequently triggering the lytic replication cascade [<xref rid="B160-viruses-16-01870" ref-type="bibr">160</xref>]. Another signaling pathway, Raf/MEK/ERK/Ets-1, is instrumental in Ras-induced RTA activation. The activation of Ras leads to the transcription of downstream genes like PAN, kaposin, ORF57, and vIL-6, which contribute to the lytic cycle of KSHV [<xref rid="B161-viruses-16-01870" ref-type="bibr">161</xref>]. In hypoxic conditions, HIF-1&#x003b1; and HIF-2&#x003b1; activate the RTA promoter directly through hypoxia response elements. This promotes KSHV reactivation under low oxygen conditions, which is commonly observed in Kaposi&#x02019;s sarcoma lesions [<xref rid="B144-viruses-16-01870" ref-type="bibr">144</xref>]. Recently, our group found that RUNX3 is upregulated at the transcriptional level by the NF-&#x003ba;B signaling pathway in KSHV-infected SLK cells and B lymphocytes during the reactivation of KSHV. Functionally, RUNX3 interacts with the KSHV genome and impairs viral replication via a mechanism of transcriptional repression, which is linked to its capacity to bind DNA and ATP [<xref rid="B23-viruses-16-01870" ref-type="bibr">23</xref>].</p></sec></sec><sec id="sec4-viruses-16-01870"><title>4. Future Perspectives</title><p>There is substantial evidence indicating that the establishment of latency and the reactivation of KSHV are intricately connected to both epigenetic and transcriptional regulation. However, the mechanisms by which these regulatory processes influence the KSHV genome are intricate and dynamic. The complex interplay of both positive and negative epigenetic regulation of KSHV transcription is inextricably linked to the various stages of the KSHV life cycle. During latency, the viral genome is maintained in an epigenetically repressed state, characterized by limited gene expression, allowing for episomal replication while simultaneously preventing immune activation. Under some certain conditions, the fate of KSHV is rewriting. The epigenetic and transcriptional repression of the viral genome is alleviated, and the viral chromatin structure is maintained in an active state, resulting in an increased expression of various lytic viral proteins. This complex epigenetic and transcriptional program requires a variety of epigenetic modifications and a plethora of transcriptional regulators within the host cell. However, what drives, organizes, and regulates such an orderly, dynamic, and precise process remains to be further explored. It is important to visualize the association between the KSHV genome and cellular epigenetic factors. Specifically, demonstrating the dynamic binding of chromatin remodeling factors and SMC complexes to the KSHV genome is essential for understanding how KSHV maintains latency or reactivates into lytic replication. Rapidly advancing genome-wide and spatial sequencing approaches with increased resolutions will significantly enhance our understanding of the epigenetic modifications in the KSHV viral genome. In addition, a more focused investigation into the binding characteristics of transcription factors associated with KSHV is crucial. Currently, we lack a comprehensive characterization of certain key regulatory factor-binding sequences within the KSHV genome. For instance, the RTA response elements within the vIL-6 promoter do not share significant similarity with the conserved sequences found in the PAN and K12 promoters [<xref rid="B130-viruses-16-01870" ref-type="bibr">130</xref>]. However, rapid advancements in bioinformatics and structural analysis techniques have greatly enhanced our ability to handle large-scale complex datasets. This progress enables us to systematically describe and summarize these binding characteristics, providing substantial support for our efforts to combat KSHV-related diseases.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Writing&#x02014;original draft preparation, C.H. and D.N.; writing&#x02014;review and editing, K.L.; visualization, C.H. and D.N.; funding acquisition, K.L. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-viruses-16-01870"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chang</surname><given-names>Y.</given-names></name>
<name><surname>Cesarman</surname><given-names>E.</given-names></name>
<name><surname>Pessin</surname><given-names>M.S.</given-names></name>
<name><surname>Lee</surname><given-names>F.</given-names></name>
<name><surname>Culpepper</surname><given-names>J.</given-names></name>
<name><surname>Knowles</surname><given-names>D.M.</given-names></name>
<name><surname>Moore</surname><given-names>P.S.</given-names></name>
</person-group><article-title>Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi&#x02019;s sarcoma</article-title><source>Science</source><year>1994</year><volume>266</volume><fpage>1865</fpage><lpage>1869</lpage><pub-id pub-id-type="doi">10.1126/science.7997879</pub-id><pub-id pub-id-type="pmid">7997879</pub-id>
</element-citation></ref><ref id="B2-viruses-16-01870"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Polizzotto</surname><given-names>M.N.</given-names></name>
<name><surname>Uldrick</surname><given-names>T.S.</given-names></name>
<name><surname>Hu</surname><given-names>D.</given-names></name>
<name><surname>Yarchoan</surname><given-names>R.</given-names></name>
</person-group><article-title>Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome</article-title><source>Front. Microbiol.</source><year>2012</year><volume>3</volume><elocation-id>73</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2012.00073</pub-id><pub-id pub-id-type="pmid">22403576</pub-id>
</element-citation></ref><ref id="B3-viruses-16-01870"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Soulier</surname><given-names>J.</given-names></name>
<name><surname>Grollet</surname><given-names>L.</given-names></name>
<name><surname>Oksenhendler</surname><given-names>E.</given-names></name>
<name><surname>Cacoub</surname><given-names>P.</given-names></name>
<name><surname>Cazals-Hatem</surname><given-names>D.</given-names></name>
<name><surname>Babinet</surname><given-names>P.</given-names></name>
<name><surname>d&#x02019;Agay</surname><given-names>M.F.</given-names></name>
<name><surname>Clauvel</surname><given-names>J.P.</given-names></name>
<name><surname>Raphael</surname><given-names>M.</given-names></name>
<name><surname>Degos</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman&#x02019;s disease</article-title><source>Blood</source><year>1995</year><volume>86</volume><fpage>1276</fpage><lpage>1280</lpage><pub-id pub-id-type="doi">10.1182/blood.V86.4.1276.bloodjournal8641276</pub-id><pub-id pub-id-type="pmid">7632932</pub-id>
</element-citation></ref><ref id="B4-viruses-16-01870"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cesarman</surname><given-names>E.</given-names></name>
<name><surname>Chang</surname><given-names>Y.</given-names></name>
<name><surname>Moore</surname><given-names>P.S.</given-names></name>
<name><surname>Said</surname><given-names>J.W.</given-names></name>
<name><surname>Knowles</surname><given-names>D.M.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas</article-title><source>N. Engl. J. Med.</source><year>1995</year><volume>332</volume><fpage>1186</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1056/NEJM199505043321802</pub-id><pub-id pub-id-type="pmid">7700311</pub-id>
</element-citation></ref><ref id="B5-viruses-16-01870"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arias</surname><given-names>C.</given-names></name>
<name><surname>Weisburd</surname><given-names>B.</given-names></name>
<name><surname>Stern-Ginossar</surname><given-names>N.</given-names></name>
<name><surname>Mercier</surname><given-names>A.</given-names></name>
<name><surname>Madrid</surname><given-names>A.S.</given-names></name>
<name><surname>Bellare</surname><given-names>P.</given-names></name>
<name><surname>Holdorf</surname><given-names>M.</given-names></name>
<name><surname>Weissman</surname><given-names>J.S.</given-names></name>
<name><surname>Ganem</surname><given-names>D.</given-names></name>
</person-group><article-title>KSHV 2.0: A comprehensive annotation of the Kaposi&#x02019;s sarcoma-associated herpesvirus genome using next-generation sequencing reveals novel genomic and functional features</article-title><source>PLoS Pathog.</source><year>2014</year><volume>10</volume><elocation-id>e1003847</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003847</pub-id><pub-id pub-id-type="pmid">24453964</pub-id>
</element-citation></ref><ref id="B6-viruses-16-01870"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Prazs&#x000e1;k</surname><given-names>I.</given-names></name>
<name><surname>Tomb&#x000e1;cz</surname><given-names>D.</given-names></name>
<name><surname>F&#x000fc;l&#x000f6;p</surname><given-names>&#x000c1;.</given-names></name>
<name><surname>Torma</surname><given-names>G.</given-names></name>
<name><surname>Guly&#x000e1;s</surname><given-names>G.</given-names></name>
<name><surname>D&#x000f6;rm&#x00151;</surname><given-names>&#x000c1;.</given-names></name>
<name><surname>Kakuk</surname><given-names>B.</given-names></name>
<name><surname>McKenzie Spires</surname><given-names>L.</given-names></name>
<name><surname>Toth</surname><given-names>Z.</given-names></name>
<name><surname>Boldogk&#x00151;i</surname><given-names>Z.</given-names></name>
</person-group><article-title>KSHV 3.0: A state-of-the-art annotation of the Kaposi&#x02019;s sarcoma-associated herpesvirus transcriptome using cross-platform sequencing</article-title><source>mSystems</source><year>2024</year><volume>9</volume><fpage>e0100723</fpage><pub-id pub-id-type="doi">10.1128/msystems.01007-23</pub-id><pub-id pub-id-type="pmid">38206015</pub-id>
</element-citation></ref><ref id="B7-viruses-16-01870"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Russo</surname><given-names>J.J.</given-names></name>
<name><surname>Bohenzky</surname><given-names>R.A.</given-names></name>
<name><surname>Chien</surname><given-names>M.C.</given-names></name>
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Yan</surname><given-names>M.</given-names></name>
<name><surname>Maddalena</surname><given-names>D.</given-names></name>
<name><surname>Parry</surname><given-names>J.P.</given-names></name>
<name><surname>Peruzzi</surname><given-names>D.</given-names></name>
<name><surname>Edelman</surname><given-names>I.S.</given-names></name>
<name><surname>Chang</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1996</year><volume>93</volume><fpage>14862</fpage><lpage>14867</lpage><pub-id pub-id-type="doi">10.1073/pnas.93.25.14862</pub-id><pub-id pub-id-type="pmid">8962146</pub-id>
</element-citation></ref><ref id="B8-viruses-16-01870"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ballestas</surname><given-names>M.E.</given-names></name>
<name><surname>Chatis</surname><given-names>P.A.</given-names></name>
<name><surname>Kaye</surname><given-names>K.M.</given-names></name>
</person-group><article-title>Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen</article-title><source>Science</source><year>1999</year><volume>284</volume><fpage>641</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1126/science.284.5414.641</pub-id><pub-id pub-id-type="pmid">10213686</pub-id>
</element-citation></ref><ref id="B9-viruses-16-01870"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mesri</surname><given-names>E.A.</given-names></name>
<name><surname>Cesarman</surname><given-names>E.</given-names></name>
<name><surname>Boshoff</surname><given-names>C.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s sarcoma and its associated herpesvirus</article-title><source>Nat. Rev. Cancer</source><year>2010</year><volume>10</volume><fpage>707</fpage><lpage>719</lpage><pub-id pub-id-type="doi">10.1038/nrc2888</pub-id><pub-id pub-id-type="pmid">20865011</pub-id>
</element-citation></ref><ref id="B10-viruses-16-01870"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aneja</surname><given-names>K.K.</given-names></name>
<name><surname>Yuan</surname><given-names>Y.</given-names></name>
</person-group><article-title>Reactivation and Lytic Replication of Kaposi&#x02019;s Sarcoma-Associated Herpesvirus: An Update</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><elocation-id>613</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2017.00613</pub-id><pub-id pub-id-type="pmid">28473805</pub-id>
</element-citation></ref><ref id="B11-viruses-16-01870"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miller</surname><given-names>G.</given-names></name>
<name><surname>Heston</surname><given-names>L.</given-names></name>
<name><surname>Grogan</surname><given-names>E.</given-names></name>
<name><surname>Gradoville</surname><given-names>L.</given-names></name>
<name><surname>Rigsby</surname><given-names>M.</given-names></name>
<name><surname>Sun</surname><given-names>R.</given-names></name>
<name><surname>Shedd</surname><given-names>D.</given-names></name>
<name><surname>Kushnaryov</surname><given-names>V.M.</given-names></name>
<name><surname>Grossberg</surname><given-names>S.</given-names></name>
<name><surname>Chang</surname><given-names>Y.</given-names></name>
</person-group><article-title>Selective switch between latency and lytic replication of Kaposi&#x02019;s sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells</article-title><source>J. Virol.</source><year>1997</year><volume>71</volume><fpage>314</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1128/jvi.71.1.314-324.1997</pub-id><pub-id pub-id-type="pmid">8985352</pub-id>
</element-citation></ref><ref id="B12-viruses-16-01870"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Ueda</surname><given-names>K.</given-names></name>
<name><surname>Sakakibara</surname><given-names>S.</given-names></name>
<name><surname>Okuno</surname><given-names>T.</given-names></name>
<name><surname>Parravicini</surname><given-names>C.</given-names></name>
<name><surname>Corbellino</surname><given-names>M.</given-names></name>
<name><surname>Yamanishi</surname><given-names>K.</given-names></name>
</person-group><article-title>Activation of latent Kaposi&#x02019;s sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2001</year><volume>98</volume><fpage>4119</fpage><lpage>4124</lpage><pub-id pub-id-type="doi">10.1073/pnas.051004198</pub-id><pub-id pub-id-type="pmid">11274437</pub-id>
</element-citation></ref><ref id="B13-viruses-16-01870"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jenner</surname><given-names>R.G.</given-names></name>
<name><surname>Alb&#x000e0;</surname><given-names>M.M.</given-names></name>
<name><surname>Boshoff</surname><given-names>C.</given-names></name>
<name><surname>Kellam</surname><given-names>P.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays</article-title><source>J. Virol.</source><year>2001</year><volume>75</volume><fpage>891</fpage><lpage>902</lpage><pub-id pub-id-type="doi">10.1128/JVI.75.2.891-902.2001</pub-id><pub-id pub-id-type="pmid">11134302</pub-id>
</element-citation></ref><ref id="B14-viruses-16-01870"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Izumiya</surname><given-names>Y.</given-names></name>
<name><surname>Izumiya</surname><given-names>C.</given-names></name>
<name><surname>Hsia</surname><given-names>D.</given-names></name>
<name><surname>Ellison</surname><given-names>T.J.</given-names></name>
<name><surname>Luciw</surname><given-names>P.A.</given-names></name>
<name><surname>Kung</surname><given-names>H.J.</given-names></name>
</person-group><article-title>NF-kappaB serves as a cellular sensor of Kaposi&#x02019;s sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator</article-title><source>J. Virol.</source><year>2009</year><volume>83</volume><fpage>4435</fpage><lpage>4446</lpage><pub-id pub-id-type="doi">10.1128/JVI.01999-08</pub-id><pub-id pub-id-type="pmid">19244329</pub-id>
</element-citation></ref><ref id="B15-viruses-16-01870"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ye</surname><given-names>J.</given-names></name>
<name><surname>Shedd</surname><given-names>D.</given-names></name>
<name><surname>Miller</surname><given-names>G.</given-names></name>
</person-group><article-title>An Sp1 response element in the Kaposi&#x02019;s sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate</article-title><source>J. Virol.</source><year>2005</year><volume>79</volume><fpage>1397</fpage><lpage>1408</lpage><pub-id pub-id-type="doi">10.1128/JVI.79.3.1397-1408.2005</pub-id><pub-id pub-id-type="pmid">15650166</pub-id>
</element-citation></ref><ref id="B16-viruses-16-01870"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ye</surname><given-names>F.C.</given-names></name>
<name><surname>Zhou</surname><given-names>F.C.</given-names></name>
<name><surname>Xie</surname><given-names>J.P.</given-names></name>
<name><surname>Kang</surname><given-names>T.</given-names></name>
<name><surname>Greene</surname><given-names>W.</given-names></name>
<name><surname>Kuhne</surname><given-names>K.</given-names></name>
<name><surname>Lei</surname><given-names>X.F.</given-names></name>
<name><surname>Li</surname><given-names>Q.H.</given-names></name>
<name><surname>Gao</surname><given-names>S.J.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: A novel mechanism of virus control of latency</article-title><source>J. Virol.</source><year>2008</year><volume>82</volume><fpage>4235</fpage><lpage>4249</lpage><pub-id pub-id-type="doi">10.1128/JVI.02370-07</pub-id><pub-id pub-id-type="pmid">18305042</pub-id>
</element-citation></ref><ref id="B17-viruses-16-01870"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gwack</surname><given-names>Y.</given-names></name>
<name><surname>Hwang</surname><given-names>S.</given-names></name>
<name><surname>Lim</surname><given-names>C.</given-names></name>
<name><surname>Won</surname><given-names>Y.S.</given-names></name>
<name><surname>Lee</surname><given-names>C.H.</given-names></name>
<name><surname>Choe</surname><given-names>J.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s Sarcoma-associated herpesvirus open reading frame 50 stimulates the transcriptional activity of STAT3</article-title><source>J. Biol. Chem.</source><year>2002</year><volume>277</volume><fpage>6438</fpage><lpage>6442</lpage><pub-id pub-id-type="doi">10.1074/jbc.M108289200</pub-id><pub-id pub-id-type="pmid">11741976</pub-id>
</element-citation></ref><ref id="B18-viruses-16-01870"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sakakibara</surname><given-names>S.</given-names></name>
<name><surname>Ueda</surname><given-names>K.</given-names></name>
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Okuno</surname><given-names>T.</given-names></name>
<name><surname>Yamanishi</surname><given-names>K.</given-names></name>
</person-group><article-title>Octamer-binding sequence is a key element for the autoregulation of Kaposi&#x02019;s sarcoma-associated herpesvirus ORF50/Lyta gene expression</article-title><source>J. Virol.</source><year>2001</year><volume>75</volume><fpage>6894</fpage><lpage>6900</lpage><pub-id pub-id-type="doi">10.1128/JVI.75.15.6894-6900.2001</pub-id><pub-id pub-id-type="pmid">11435569</pub-id>
</element-citation></ref><ref id="B19-viruses-16-01870"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chang</surname><given-names>P.J.</given-names></name>
<name><surname>Chen</surname><given-names>L.W.</given-names></name>
<name><surname>Shih</surname><given-names>Y.C.</given-names></name>
<name><surname>Tsai</surname><given-names>P.H.</given-names></name>
<name><surname>Liu</surname><given-names>A.C.</given-names></name>
<name><surname>Hung</surname><given-names>C.H.</given-names></name>
<name><surname>Liou</surname><given-names>J.Y.</given-names></name>
<name><surname>Wang</surname><given-names>S.S.</given-names></name>
</person-group><article-title>Role of the cellular transcription factor YY1 in the latent-lytic switch of Kaposi&#x02019;s sarcoma-associated herpesvirus</article-title><source>Virology</source><year>2011</year><volume>413</volume><fpage>194</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2011.02.013</pub-id><pub-id pub-id-type="pmid">21376359</pub-id>
</element-citation></ref><ref id="B20-viruses-16-01870"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>R.</given-names></name>
<name><surname>Liang</surname><given-names>D.</given-names></name>
<name><surname>Gao</surname><given-names>Y.</given-names></name>
<name><surname>Lan</surname><given-names>K.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency</article-title><source>J. Virol.</source><year>2014</year><volume>88</volume><fpage>7331</fpage><lpage>7344</lpage><pub-id pub-id-type="doi">10.1128/JVI.00596-14</pub-id><pub-id pub-id-type="pmid">24741090</pub-id>
</element-citation></ref><ref id="B21-viruses-16-01870"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>He</surname><given-names>Z.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Liang</surname><given-names>D.</given-names></name>
<name><surname>Wang</surname><given-names>Z.</given-names></name>
<name><surname>Robertson</surname><given-names>E.S.</given-names></name>
<name><surname>Lan</surname><given-names>K.</given-names></name>
</person-group><article-title>Cellular corepressor TLE2 inhibits replication-and-transcription- activator-mediated transactivation and lytic reactivation of Kaposi&#x02019;s sarcoma-associated herpesvirus</article-title><source>J. Virol.</source><year>2010</year><volume>84</volume><fpage>2047</fpage><lpage>2062</lpage><pub-id pub-id-type="doi">10.1128/JVI.01984-09</pub-id><pub-id pub-id-type="pmid">19939918</pub-id>
</element-citation></ref><ref id="B22-viruses-16-01870"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>Z.</given-names></name>
<name><surname>Wood</surname><given-names>C.</given-names></name>
</person-group><article-title>The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi&#x02019;s sarcoma-associated herpesvirus</article-title><source>J. Virol.</source><year>2007</year><volume>81</volume><fpage>6294</fpage><lpage>6306</lpage><pub-id pub-id-type="doi">10.1128/JVI.02648-06</pub-id><pub-id pub-id-type="pmid">17409159</pub-id>
</element-citation></ref><ref id="B23-viruses-16-01870"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ren</surname><given-names>P.</given-names></name>
<name><surname>Niu</surname><given-names>D.</given-names></name>
<name><surname>Chang</surname><given-names>S.</given-names></name>
<name><surname>Yu</surname><given-names>L.</given-names></name>
<name><surname>Ren</surname><given-names>J.</given-names></name>
<name><surname>Ma</surname><given-names>Y.</given-names></name>
<name><surname>Lan</surname><given-names>K.</given-names></name>
</person-group><article-title>RUNX3 inhibits KSHV lytic replication by binding to the viral genome and repressing transcription</article-title><source>J. Virol.</source><year>2024</year><volume>98</volume><fpage>e0156723</fpage><pub-id pub-id-type="doi">10.1128/jvi.01567-23</pub-id><pub-id pub-id-type="pmid">38197631</pub-id>
</element-citation></ref><ref id="B24-viruses-16-01870"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lan</surname><given-names>K.</given-names></name>
<name><surname>Kuppers</surname><given-names>D.A.</given-names></name>
<name><surname>Robertson</surname><given-names>E.S.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway</article-title><source>J. Virol.</source><year>2005</year><volume>79</volume><fpage>3468</fpage><lpage>3478</lpage><pub-id pub-id-type="doi">10.1128/JVI.79.6.3468-3478.2005</pub-id><pub-id pub-id-type="pmid">15731241</pub-id>
</element-citation></ref><ref id="B25-viruses-16-01870"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lan</surname><given-names>K.</given-names></name>
<name><surname>Kuppers</surname><given-names>D.A.</given-names></name>
<name><surname>Verma</surname><given-names>S.C.</given-names></name>
<name><surname>Robertson</surname><given-names>E.S.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: A potential mechanism for virus-mediated control of latency</article-title><source>J. Virol.</source><year>2004</year><volume>78</volume><fpage>6585</fpage><lpage>6594</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.12.6585-6594.2004</pub-id><pub-id pub-id-type="pmid">15163750</pub-id>
</element-citation></ref><ref id="B26-viruses-16-01870"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Renne</surname><given-names>R.</given-names></name>
<name><surname>Barry</surname><given-names>C.</given-names></name>
<name><surname>Dittmer</surname><given-names>D.</given-names></name>
<name><surname>Compitello</surname><given-names>N.</given-names></name>
<name><surname>Brown</surname><given-names>P.O.</given-names></name>
<name><surname>Ganem</surname><given-names>D.</given-names></name>
</person-group><article-title>Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi&#x02019;s sarcoma-associated herpesvirus</article-title><source>J. Virol.</source><year>2001</year><volume>75</volume><fpage>458</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1128/JVI.75.1.458-468.2001</pub-id><pub-id pub-id-type="pmid">11119614</pub-id>
</element-citation></ref><ref id="B27-viruses-16-01870"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lukac</surname><given-names>D.M.</given-names></name>
<name><surname>Kirshner</surname><given-names>J.R.</given-names></name>
<name><surname>Ganem</surname><given-names>D.</given-names></name>
</person-group><article-title>Transcriptional activation by the product of open reading frame 50 of Kaposi&#x02019;s sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells</article-title><source>J. Virol.</source><year>1999</year><volume>73</volume><fpage>9348</fpage><lpage>9361</lpage><pub-id pub-id-type="doi">10.1128/JVI.73.11.9348-9361.1999</pub-id><pub-id pub-id-type="pmid">10516043</pub-id>
</element-citation></ref><ref id="B28-viruses-16-01870"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liao</surname><given-names>W.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
<name><surname>Lin</surname><given-names>S.F.</given-names></name>
<name><surname>Kung</surname><given-names>H.J.</given-names></name>
<name><surname>Giam</surname><given-names>C.Z.</given-names></name>
</person-group><article-title>K-bZIP of Kaposi&#x02019;s sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) binds KSHV/HHV-8 Rta and represses Rta-mediated transactivation</article-title><source>J. Virol.</source><year>2003</year><volume>77</volume><fpage>3809</fpage><lpage>3815</lpage><pub-id pub-id-type="doi">10.1128/JVI.77.6.3809-3815.2003</pub-id><pub-id pub-id-type="pmid">12610155</pub-id>
</element-citation></ref><ref id="B29-viruses-16-01870"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liang</surname><given-names>D.</given-names></name>
<name><surname>Lin</surname><given-names>X.</given-names></name>
<name><surname>Lan</surname><given-names>K.</given-names></name>
</person-group><article-title>Looking at Kaposi&#x02019;s Sarcoma-Associated Herpesvirus-Host Interactions from a microRNA Viewpoint</article-title><source>Front. Microbiol.</source><year>2011</year><volume>2</volume><elocation-id>271</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2011.00271</pub-id><pub-id pub-id-type="pmid">22275910</pub-id>
</element-citation></ref><ref id="B30-viruses-16-01870"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Caiafa</surname><given-names>P.</given-names></name>
<name><surname>Zampieri</surname><given-names>M.</given-names></name>
</person-group><article-title>DNA methylation and chromatin structure: The puzzling CpG islands</article-title><source>J Cell Biochem</source><year>2005</year><volume>94</volume><fpage>257</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1002/jcb.20325</pub-id><pub-id pub-id-type="pmid">15546139</pub-id>
</element-citation></ref><ref id="B31-viruses-16-01870"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jones</surname><given-names>P.A.</given-names></name>
</person-group><article-title>Functions of DNA methylation: Islands, start sites, gene bodies and beyond</article-title><source>Nat. Rev. Genet.</source><year>2012</year><volume>13</volume><fpage>484</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1038/nrg3230</pub-id><pub-id pub-id-type="pmid">22641018</pub-id>
</element-citation></ref><ref id="B32-viruses-16-01870"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shamay</surname><given-names>M.</given-names></name>
<name><surname>Krithivas</surname><given-names>A.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Hayward</surname><given-names>S.D.</given-names></name>
</person-group><article-title>Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi&#x02019;s sarcoma-associated herpesvirus LANA</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2006</year><volume>103</volume><fpage>14554</fpage><lpage>14559</lpage><pub-id pub-id-type="doi">10.1073/pnas.0604469103</pub-id><pub-id pub-id-type="pmid">16983096</pub-id>
</element-citation></ref><ref id="B33-viruses-16-01870"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Di Bartolo</surname><given-names>D.L.</given-names></name>
<name><surname>Cannon</surname><given-names>M.</given-names></name>
<name><surname>Liu</surname><given-names>Y.F.</given-names></name>
<name><surname>Renne</surname><given-names>R.</given-names></name>
<name><surname>Chadburn</surname><given-names>A.</given-names></name>
<name><surname>Boshoff</surname><given-names>C.</given-names></name>
<name><surname>Cesarman</surname><given-names>E.</given-names></name>
</person-group><article-title>KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor</article-title><source>Blood</source><year>2008</year><volume>111</volume><fpage>4731</fpage><lpage>4740</lpage><pub-id pub-id-type="doi">10.1182/blood-2007-09-110544</pub-id><pub-id pub-id-type="pmid">18199825</pub-id>
</element-citation></ref><ref id="B34-viruses-16-01870"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wu</surname><given-names>J.</given-names></name>
<name><surname>Xu</surname><given-names>Y.</given-names></name>
<name><surname>Mo</surname><given-names>D.</given-names></name>
<name><surname>Huang</surname><given-names>P.</given-names></name>
<name><surname>Sun</surname><given-names>R.</given-names></name>
<name><surname>Huang</surname><given-names>L.</given-names></name>
<name><surname>Pan</surname><given-names>S.</given-names></name>
<name><surname>Xu</surname><given-names>J.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus (KSHV) vIL-6 promotes cell proliferation and migration by upregulating DNMT1 via STAT3 activation</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e93478</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0093478</pub-id><pub-id pub-id-type="pmid">24675762</pub-id>
</element-citation></ref><ref id="B35-viruses-16-01870"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Singh</surname><given-names>R.K.</given-names></name>
<name><surname>Lang</surname><given-names>F.</given-names></name>
<name><surname>Pei</surname><given-names>Y.</given-names></name>
<name><surname>Jha</surname><given-names>H.C.</given-names></name>
<name><surname>Robertson</surname><given-names>E.S.</given-names></name>
</person-group><article-title>Metabolic reprogramming of Kaposi&#x02019;s sarcoma associated herpes virus infected B-cells in hypoxia</article-title><source>PLoS Pathog.</source><year>2018</year><volume>14</volume><elocation-id>e1007062</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007062</pub-id><pub-id pub-id-type="pmid">29746587</pub-id>
</element-citation></ref><ref id="B36-viruses-16-01870"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>F.</given-names></name>
<name><surname>Stedman</surname><given-names>W.</given-names></name>
<name><surname>Yousef</surname><given-names>M.</given-names></name>
<name><surname>Renne</surname><given-names>R.</given-names></name>
<name><surname>Lieberman</surname><given-names>P.M.</given-names></name>
</person-group><article-title>Epigenetic regulation of Kaposi&#x02019;s sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway</article-title><source>J. Virol.</source><year>2010</year><volume>84</volume><fpage>2697</fpage><lpage>2706</lpage><pub-id pub-id-type="doi">10.1128/JVI.01997-09</pub-id><pub-id pub-id-type="pmid">20071580</pub-id>
</element-citation></ref><ref id="B37-viruses-16-01870"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>G&#x000fc;nther</surname><given-names>T.</given-names></name>
<name><surname>Grundhoff</surname><given-names>A.</given-names></name>
</person-group><article-title>The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes</article-title><source>PLoS Pathog.</source><year>2010</year><volume>6</volume><elocation-id>e1000935</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000935</pub-id><pub-id pub-id-type="pmid">20532208</pub-id>
</element-citation></ref><ref id="B38-viruses-16-01870"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Darst</surname><given-names>R.P.</given-names></name>
<name><surname>Haecker</surname><given-names>I.</given-names></name>
<name><surname>Pardo</surname><given-names>C.E.</given-names></name>
<name><surname>Renne</surname><given-names>R.</given-names></name>
<name><surname>Kladde</surname><given-names>M.P.</given-names></name>
</person-group><article-title>Epigenetic diversity of Kaposi&#x02019;s sarcoma-associated herpesvirus</article-title><source>Nucleic Acids Res.</source><year>2013</year><volume>41</volume><fpage>2993</fpage><lpage>3009</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt033</pub-id><pub-id pub-id-type="pmid">23361465</pub-id>
</element-citation></ref><ref id="B39-viruses-16-01870"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Journo</surname><given-names>G.</given-names></name>
<name><surname>Ahuja</surname><given-names>A.</given-names></name>
<name><surname>Dias-Polak</surname><given-names>D.</given-names></name>
<name><surname>Eran</surname><given-names>Y.</given-names></name>
<name><surname>Bergman</surname><given-names>R.</given-names></name>
<name><surname>Shamay</surname><given-names>M.</given-names></name>
</person-group><article-title>Global CpG DNA Methylation Footprint in Kaposi&#x02019;s Sarcoma</article-title><source>Front. Cell. Infect. Microbiol.</source><year>2021</year><volume>11</volume><elocation-id>666143</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2021.666143</pub-id><pub-id pub-id-type="pmid">34307191</pub-id>
</element-citation></ref><ref id="B40-viruses-16-01870"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Journo</surname><given-names>G.</given-names></name>
<name><surname>Tushinsky</surname><given-names>C.</given-names></name>
<name><surname>Shterngas</surname><given-names>A.</given-names></name>
<name><surname>Avital</surname><given-names>N.</given-names></name>
<name><surname>Eran</surname><given-names>Y.</given-names></name>
<name><surname>Karpuj</surname><given-names>M.V.</given-names></name>
<name><surname>Frenkel-Morgenstern</surname><given-names>M.</given-names></name>
<name><surname>Shamay</surname><given-names>M.</given-names></name>
</person-group><article-title>Modulation of Cellular CpG DNA Methylation by Kaposi&#x02019;s Sarcoma-Associated Herpesvirus</article-title><source>J. Virol.</source><year>2018</year><volume>92</volume><fpage>e00008-18</fpage><pub-id pub-id-type="doi">10.1128/JVI.00008-18</pub-id><pub-id pub-id-type="pmid">29899086</pub-id>
</element-citation></ref><ref id="B41-viruses-16-01870"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Spivakov</surname><given-names>M.</given-names></name>
<name><surname>Fisher</surname><given-names>A.G.</given-names></name>
</person-group><article-title>Epigenetic signatures of stem-cell identity</article-title><source>Nat. Rev. Genet.</source><year>2007</year><volume>8</volume><fpage>263</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1038/nrg2046</pub-id><pub-id pub-id-type="pmid">17363975</pub-id>
</element-citation></ref><ref id="B42-viruses-16-01870"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Renne</surname><given-names>R.</given-names></name>
<name><surname>Lagunoff</surname><given-names>M.</given-names></name>
<name><surname>Zhong</surname><given-names>W.</given-names></name>
<name><surname>Ganem</surname><given-names>D.</given-names></name>
</person-group><article-title>The size and conformation of Kaposi&#x02019;s sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions</article-title><source>J. Virol.</source><year>1996</year><volume>70</volume><fpage>8151</fpage><lpage>8154</lpage><pub-id pub-id-type="doi">10.1128/jvi.70.11.8151-8154.1996</pub-id><pub-id pub-id-type="pmid">8892944</pub-id>
</element-citation></ref><ref id="B43-viruses-16-01870"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Toth</surname><given-names>Z.</given-names></name>
<name><surname>Brulois</surname><given-names>K.</given-names></name>
<name><surname>Jung</surname><given-names>J.U.</given-names></name>
</person-group><article-title>The chromatin landscape of Kaposi&#x02019;s sarcoma-associated herpesvirus</article-title><source>Viruses</source><year>2013</year><volume>5</volume><fpage>1346</fpage><lpage>1373</lpage><pub-id pub-id-type="doi">10.3390/v5051346</pub-id><pub-id pub-id-type="pmid">23698402</pub-id>
</element-citation></ref><ref id="B44-viruses-16-01870"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Toth</surname><given-names>Z.</given-names></name>
<name><surname>Maglinte</surname><given-names>D.T.</given-names></name>
<name><surname>Lee</surname><given-names>S.H.</given-names></name>
<name><surname>Lee</surname><given-names>H.R.</given-names></name>
<name><surname>Wong</surname><given-names>L.Y.</given-names></name>
<name><surname>Brulois</surname><given-names>K.F.</given-names></name>
<name><surname>Lee</surname><given-names>S.</given-names></name>
<name><surname>Buckley</surname><given-names>J.D.</given-names></name>
<name><surname>Laird</surname><given-names>P.W.</given-names></name>
<name><surname>Marquez</surname><given-names>V.E.</given-names></name>
<etal/>
</person-group><article-title>Epigenetic analysis of KSHV latent and lytic genomes</article-title><source>PLoS Pathog.</source><year>2010</year><volume>6</volume><elocation-id>e1001013</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1001013</pub-id><pub-id pub-id-type="pmid">20661424</pub-id>
</element-citation></ref><ref id="B45-viruses-16-01870"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bernstein</surname><given-names>B.E.</given-names></name>
<name><surname>Mikkelsen</surname><given-names>T.S.</given-names></name>
<name><surname>Xie</surname><given-names>X.</given-names></name>
<name><surname>Kamal</surname><given-names>M.</given-names></name>
<name><surname>Huebert</surname><given-names>D.J.</given-names></name>
<name><surname>Cuff</surname><given-names>J.</given-names></name>
<name><surname>Fry</surname><given-names>B.</given-names></name>
<name><surname>Meissner</surname><given-names>A.</given-names></name>
<name><surname>Wernig</surname><given-names>M.</given-names></name>
<name><surname>Plath</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>A bivalent chromatin structure marks key developmental genes in embryonic stem cells</article-title><source>Cell</source><year>2006</year><volume>125</volume><fpage>315</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.02.041</pub-id><pub-id pub-id-type="pmid">16630819</pub-id>
</element-citation></ref><ref id="B46-viruses-16-01870"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Toth</surname><given-names>Z.</given-names></name>
<name><surname>Brulois</surname><given-names>K.</given-names></name>
<name><surname>Lee</surname><given-names>H.R.</given-names></name>
<name><surname>Izumiya</surname><given-names>Y.</given-names></name>
<name><surname>Tepper</surname><given-names>C.</given-names></name>
<name><surname>Kung</surname><given-names>H.J.</given-names></name>
<name><surname>Jung</surname><given-names>J.U.</given-names></name>
</person-group><article-title>Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection</article-title><source>PLoS Pathog.</source><year>2013</year><volume>9</volume><elocation-id>e1003813</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003813</pub-id><pub-id pub-id-type="pmid">24367262</pub-id>
</element-citation></ref><ref id="B47-viruses-16-01870"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Toth</surname><given-names>Z.</given-names></name>
<name><surname>Papp</surname><given-names>B.</given-names></name>
<name><surname>Brulois</surname><given-names>K.</given-names></name>
<name><surname>Choi</surname><given-names>Y.J.</given-names></name>
<name><surname>Gao</surname><given-names>S.J.</given-names></name>
<name><surname>Jung</surname><given-names>J.U.</given-names></name>
</person-group><article-title>LANA-Mediated Recruitment of Host Polycomb Repressive Complexes onto the KSHV Genome during De Novo Infection</article-title><source>PLoS Pathog.</source><year>2016</year><volume>12</volume><elocation-id>e1005878</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005878</pub-id><pub-id pub-id-type="pmid">27606464</pub-id>
</element-citation></ref><ref id="B48-viruses-16-01870"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hu</surname><given-names>J.</given-names></name>
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Turner</surname><given-names>P.C.</given-names></name>
<name><surname>Jain</surname><given-names>V.</given-names></name>
<name><surname>McIntyre</surname><given-names>L.M.</given-names></name>
<name><surname>Renne</surname><given-names>R.</given-names></name>
</person-group><article-title>LANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complex</article-title><source>PLoS Pathog</source><year>2014</year><volume>10</volume><elocation-id>e1004240</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004240</pub-id><pub-id pub-id-type="pmid">25033463</pub-id>
</element-citation></ref><ref id="B49-viruses-16-01870"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>K.Y.</given-names></name>
<name><surname>Huerta</surname><given-names>S.B.</given-names></name>
<name><surname>Izumiya</surname><given-names>C.</given-names></name>
<name><surname>Wang</surname><given-names>D.H.</given-names></name>
<name><surname>Martinez</surname><given-names>A.</given-names></name>
<name><surname>Shevchenko</surname><given-names>B.</given-names></name>
<name><surname>Kung</surname><given-names>H.J.</given-names></name>
<name><surname>Campbell</surname><given-names>M.</given-names></name>
<name><surname>Izumiya</surname><given-names>Y.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A</article-title><source>J. Virol.</source><year>2013</year><volume>87</volume><fpage>6782</fpage><lpage>6793</lpage><pub-id pub-id-type="doi">10.1128/JVI.00011-13</pub-id><pub-id pub-id-type="pmid">23576503</pub-id>
</element-citation></ref><ref id="B50-viruses-16-01870"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sakakibara</surname><given-names>S.</given-names></name>
<name><surname>Ueda</surname><given-names>K.</given-names></name>
<name><surname>Nishimura</surname><given-names>K.</given-names></name>
<name><surname>Do</surname><given-names>E.</given-names></name>
<name><surname>Ohsaki</surname><given-names>E.</given-names></name>
<name><surname>Okuno</surname><given-names>T.</given-names></name>
<name><surname>Yamanishi</surname><given-names>K.</given-names></name>
</person-group><article-title>Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi&#x02019;s sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen</article-title><source>J. Virol.</source><year>2004</year><volume>78</volume><fpage>7299</fpage><lpage>7310</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.14.7299-7310.2004</pub-id><pub-id pub-id-type="pmid">15220403</pub-id>
</element-citation></ref><ref id="B51-viruses-16-01870"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>G&#x000fc;nther</surname><given-names>T.</given-names></name>
<name><surname>Fr&#x000f6;hlich</surname><given-names>J.</given-names></name>
<name><surname>Herrde</surname><given-names>C.</given-names></name>
<name><surname>Ohno</surname><given-names>S.</given-names></name>
<name><surname>Burkhardt</surname><given-names>L.</given-names></name>
<name><surname>Adler</surname><given-names>H.</given-names></name>
<name><surname>Grundhoff</surname><given-names>A.</given-names></name>
</person-group><article-title>A comparative epigenome analysis of gammaherpesviruses suggests cis-acting sequence features as critical mediators of rapid polycomb recruitment</article-title><source>PLoS Pathog.</source><year>2019</year><volume>15</volume><elocation-id>e1007838</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007838</pub-id><pub-id pub-id-type="pmid">31671162</pub-id>
</element-citation></ref><ref id="B52-viruses-16-01870"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Naik</surname><given-names>N.G.</given-names></name>
<name><surname>Nguyen</surname><given-names>T.H.</given-names></name>
<name><surname>Roberts</surname><given-names>L.</given-names></name>
<name><surname>Fischer</surname><given-names>L.T.</given-names></name>
<name><surname>Glickman</surname><given-names>K.</given-names></name>
<name><surname>Golas</surname><given-names>G.</given-names></name>
<name><surname>Papp</surname><given-names>B.</given-names></name>
<name><surname>Toth</surname><given-names>Z.</given-names></name>
</person-group><article-title>Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV</article-title><source>PLoS Pathog.</source><year>2020</year><volume>16</volume><elocation-id>e1008268</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1008268</pub-id><pub-id pub-id-type="pmid">31923286</pub-id>
</element-citation></ref><ref id="B53-viruses-16-01870"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Strahan</surname><given-names>R.C.</given-names></name>
<name><surname>McDowell-Sargent</surname><given-names>M.</given-names></name>
<name><surname>Uppal</surname><given-names>T.</given-names></name>
<name><surname>Purushothaman</surname><given-names>P.</given-names></name>
<name><surname>Verma</surname><given-names>S.C.</given-names></name>
</person-group><article-title>KSHV encoded ORF59 modulates histone arginine methylation of the viral genome to promote viral reactivation</article-title><source>PLoS Pathog.</source><year>2017</year><volume>13</volume><elocation-id>e1006482</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006482</pub-id><pub-id pub-id-type="pmid">28678843</pub-id>
</element-citation></ref><ref id="B54-viruses-16-01870"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hiura</surname><given-names>K.</given-names></name>
<name><surname>Strahan</surname><given-names>R.</given-names></name>
<name><surname>Uppal</surname><given-names>T.</given-names></name>
<name><surname>Prince</surname><given-names>B.</given-names></name>
<name><surname>Rossetto</surname><given-names>C.C.</given-names></name>
<name><surname>Verma</surname><given-names>S.C.</given-names></name>
</person-group><article-title>KSHV ORF59 and PAN RNA Recruit Histone Demethylases to the Viral Chromatin during Lytic Reactivation</article-title><source>Viruses</source><year>2020</year><volume>12</volume><elocation-id>420</elocation-id><pub-id pub-id-type="doi">10.3390/v12040420</pub-id><pub-id pub-id-type="pmid">32283586</pub-id>
</element-citation></ref><ref id="B55-viruses-16-01870"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>F.</given-names></name>
<name><surname>Day</surname><given-names>L.</given-names></name>
<name><surname>Gao</surname><given-names>S.J.</given-names></name>
<name><surname>Lieberman</surname><given-names>P.M.</given-names></name>
</person-group><article-title>Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi&#x02019;s sarcoma-associated herpesvirus lytic transcription</article-title><source>J. Virol.</source><year>2006</year><volume>80</volume><fpage>5273</fpage><lpage>5282</lpage><pub-id pub-id-type="doi">10.1128/JVI.02541-05</pub-id><pub-id pub-id-type="pmid">16699007</pub-id>
</element-citation></ref><ref id="B56-viruses-16-01870"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>F.</given-names></name>
<name><surname>Zhou</surname><given-names>J.</given-names></name>
<name><surname>Wiedmer</surname><given-names>A.</given-names></name>
<name><surname>Madden</surname><given-names>K.</given-names></name>
<name><surname>Yuan</surname><given-names>Y.</given-names></name>
<name><surname>Lieberman</surname><given-names>P.M.</given-names></name>
</person-group><article-title>Chromatin remodeling of the Kaposi&#x02019;s sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency</article-title><source>J. Virol.</source><year>2003</year><volume>77</volume><fpage>11425</fpage><lpage>11435</lpage><pub-id pub-id-type="doi">10.1128/JVI.77.21.11425-11435.2003</pub-id><pub-id pub-id-type="pmid">14557628</pub-id>
</element-citation></ref><ref id="B57-viruses-16-01870"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vaquero</surname><given-names>A.</given-names></name>
<name><surname>Scher</surname><given-names>M.</given-names></name>
<name><surname>Lee</surname><given-names>D.</given-names></name>
<name><surname>Erdjument-Bromage</surname><given-names>H.</given-names></name>
<name><surname>Tempst</surname><given-names>P.</given-names></name>
<name><surname>Reinberg</surname><given-names>D.</given-names></name>
</person-group><article-title>Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin</article-title><source>Mol. Cell</source><year>2004</year><volume>16</volume><fpage>93</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2004.08.031</pub-id><pub-id pub-id-type="pmid">15469825</pub-id>
</element-citation></ref><ref id="B58-viruses-16-01870"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Q.</given-names></name>
<name><surname>He</surname><given-names>M.</given-names></name>
<name><surname>Zhou</surname><given-names>F.</given-names></name>
<name><surname>Ye</surname><given-names>F.</given-names></name>
<name><surname>Gao</surname><given-names>S.J.</given-names></name>
</person-group><article-title>Activation of Kaposi&#x02019;s sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: Identification of sirtuin 1 as a regulator of the KSHV life cycle</article-title><source>J. Virol.</source><year>2014</year><volume>88</volume><fpage>6355</fpage><lpage>6367</lpage><pub-id pub-id-type="doi">10.1128/JVI.00219-14</pub-id><pub-id pub-id-type="pmid">24672028</pub-id>
</element-citation></ref><ref id="B59-viruses-16-01870"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shiio</surname><given-names>Y.</given-names></name>
<name><surname>Eisenman</surname><given-names>R.N.</given-names></name>
</person-group><article-title>Histone sumoylation is associated with transcriptional repression</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2003</year><volume>100</volume><fpage>13225</fpage><lpage>13230</lpage><pub-id pub-id-type="doi">10.1073/pnas.1735528100</pub-id><pub-id pub-id-type="pmid">14578449</pub-id>
</element-citation></ref><ref id="B60-viruses-16-01870"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>W.S.</given-names></name>
<name><surname>Campbell</surname><given-names>M.</given-names></name>
<name><surname>Chang</surname><given-names>P.C.</given-names></name>
</person-group><article-title>SUMO modification of a heterochromatin histone demethylase JMJD2A enables viral gene transactivation and viral replication</article-title><source>PLoS Pathog.</source><year>2017</year><volume>13</volume><elocation-id>e1006216</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006216</pub-id><pub-id pub-id-type="pmid">28212444</pub-id>
</element-citation></ref><ref id="B61-viruses-16-01870"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Everett</surname><given-names>R.D.</given-names></name>
</person-group><article-title>DNA viruses and viral proteins that interact with PML nuclear bodies</article-title><source>Oncogene</source><year>2001</year><volume>20</volume><fpage>7266</fpage><lpage>7273</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1204759</pub-id><pub-id pub-id-type="pmid">11704855</pub-id>
</element-citation></ref><ref id="B62-viruses-16-01870"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Izumiya</surname><given-names>Y.</given-names></name>
<name><surname>Kobayashi</surname><given-names>K.</given-names></name>
<name><surname>Kim</surname><given-names>K.Y.</given-names></name>
<name><surname>Pochampalli</surname><given-names>M.</given-names></name>
<name><surname>Izumiya</surname><given-names>C.</given-names></name>
<name><surname>Shevchenko</surname><given-names>B.</given-names></name>
<name><surname>Wang</surname><given-names>D.H.</given-names></name>
<name><surname>Huerta</surname><given-names>S.B.</given-names></name>
<name><surname>Martinez</surname><given-names>A.</given-names></name>
<name><surname>Campbell</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivation</article-title><source>PLoS Pathog.</source><year>2013</year><volume>9</volume><elocation-id>e1003506</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003506</pub-id><pub-id pub-id-type="pmid">23990779</pub-id>
</element-citation></ref><ref id="B63-viruses-16-01870"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cai</surname><given-names>Q.</given-names></name>
<name><surname>Cai</surname><given-names>S.</given-names></name>
<name><surname>Zhu</surname><given-names>C.</given-names></name>
<name><surname>Verma</surname><given-names>S.C.</given-names></name>
<name><surname>Choi</surname><given-names>J.Y.</given-names></name>
<name><surname>Robertson</surname><given-names>E.S.</given-names></name>
</person-group><article-title>A unique SUMO-2-interacting motif within LANA is essential for KSHV latency</article-title><source>PLoS Pathog.</source><year>2013</year><volume>9</volume><elocation-id>e1003750</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003750</pub-id><pub-id pub-id-type="pmid">24278015</pub-id>
</element-citation></ref><ref id="B64-viruses-16-01870"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Izumiya</surname><given-names>Y.</given-names></name>
<name><surname>Izumiya</surname><given-names>C.</given-names></name>
<name><surname>Van Geelen</surname><given-names>A.</given-names></name>
<name><surname>Wang</surname><given-names>D.H.</given-names></name>
<name><surname>Lam</surname><given-names>K.S.</given-names></name>
<name><surname>Luciw</surname><given-names>P.A.</given-names></name>
<name><surname>Kung</surname><given-names>H.J.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus-encoded protein kinase and its interaction with K-bZIP</article-title><source>J. Virol.</source><year>2007</year><volume>81</volume><fpage>1072</fpage><lpage>1082</lpage><pub-id pub-id-type="doi">10.1128/JVI.01473-06</pub-id><pub-id pub-id-type="pmid">17108053</pub-id>
</element-citation></ref><ref id="B65-viruses-16-01870"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chang</surname><given-names>P.C.</given-names></name>
<name><surname>Fitzgerald</surname><given-names>L.D.</given-names></name>
<name><surname>Van Geelen</surname><given-names>A.</given-names></name>
<name><surname>Izumiya</surname><given-names>Y.</given-names></name>
<name><surname>Ellison</surname><given-names>T.J.</given-names></name>
<name><surname>Wang</surname><given-names>D.H.</given-names></name>
<name><surname>Ann</surname><given-names>D.K.</given-names></name>
<name><surname>Luciw</surname><given-names>P.A.</given-names></name>
<name><surname>Kung</surname><given-names>H.J.</given-names></name>
</person-group><article-title>Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi&#x02019;s sarcoma-associated herpesvirus and its modulation by the viral protein kinase</article-title><source>Cancer Res.</source><year>2009</year><volume>69</volume><fpage>5681</fpage><lpage>5689</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-4570</pub-id><pub-id pub-id-type="pmid">19584288</pub-id>
</element-citation></ref><ref id="B66-viruses-16-01870"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jha</surname><given-names>H.C.</given-names></name>
<name><surname>Upadhyay</surname><given-names>S.K.</given-names></name>
<name><surname>Prasad AJ</surname><given-names>M.</given-names></name>
<name><surname>Lu</surname><given-names>J.</given-names></name>
<name><surname>Cai</surname><given-names>Q.</given-names></name>
<name><surname>Saha</surname><given-names>A.</given-names></name>
<name><surname>Robertson</surname><given-names>E.S.</given-names></name>
</person-group><article-title>H2AX phosphorylation is important for LANA-mediated Kaposi&#x02019;s sarcoma-associated herpesvirus episome persistence</article-title><source>J. Virol.</source><year>2013</year><volume>87</volume><fpage>5255</fpage><lpage>5269</lpage><pub-id pub-id-type="doi">10.1128/JVI.03575-12</pub-id><pub-id pub-id-type="pmid">23449797</pub-id>
</element-citation></ref><ref id="B67-viruses-16-01870"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gwack</surname><given-names>Y.</given-names></name>
<name><surname>Baek</surname><given-names>H.J.</given-names></name>
<name><surname>Nakamura</surname><given-names>H.</given-names></name>
<name><surname>Lee</surname><given-names>S.H.</given-names></name>
<name><surname>Meisterernst</surname><given-names>M.</given-names></name>
<name><surname>Roeder</surname><given-names>R.G.</given-names></name>
<name><surname>Jung</surname><given-names>J.U.</given-names></name>
</person-group><article-title>Principal role of TRAP/mediator and SWI/SNF complexes in Kaposi&#x02019;s sarcoma-associated herpesvirus RTA-mediated lytic reactivation</article-title><source>Mol. Cell. Biol.</source><year>2003</year><volume>23</volume><fpage>2055</fpage><lpage>2067</lpage><pub-id pub-id-type="doi">10.1128/MCB.23.6.2055-2067.2003</pub-id><pub-id pub-id-type="pmid">12612078</pub-id>
</element-citation></ref><ref id="B68-viruses-16-01870"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Narlikar</surname><given-names>G.J.</given-names></name>
<name><surname>Fan</surname><given-names>H.Y.</given-names></name>
<name><surname>Kingston</surname><given-names>R.E.</given-names></name>
</person-group><article-title>Cooperation between complexes that regulate chromatin structure and transcription</article-title><source>Cell</source><year>2002</year><volume>108</volume><fpage>475</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(02)00654-2</pub-id><pub-id pub-id-type="pmid">11909519</pub-id>
</element-citation></ref><ref id="B69-viruses-16-01870"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hwang</surname><given-names>S.</given-names></name>
<name><surname>Lee</surname><given-names>D.</given-names></name>
<name><surname>Gwack</surname><given-names>Y.</given-names></name>
<name><surname>Min</surname><given-names>H.</given-names></name>
<name><surname>Choe</surname><given-names>J.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus K8 protein interacts with hSNF5</article-title><source>J. Gen. Virol.</source><year>2003</year><volume>84</volume><fpage>665</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1099/vir.0.18699-0</pub-id><pub-id pub-id-type="pmid">12604819</pub-id>
</element-citation></ref><ref id="B70-viruses-16-01870"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hirano</surname><given-names>T.</given-names></name>
</person-group><article-title>SMC proteins and chromosome mechanics: From bacteria to humans</article-title><source>Philos. Trans. R. Soc. London. Ser. B Biol. Sci.</source><year>2005</year><volume>360</volume><fpage>507</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1098/rstb.2004.1606</pub-id><pub-id pub-id-type="pmid">15897176</pub-id>
</element-citation></ref><ref id="B71-viruses-16-01870"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ong</surname><given-names>C.T.</given-names></name>
<name><surname>Corces</surname><given-names>V.G.</given-names></name>
</person-group><article-title>CTCF: An architectural protein bridging genome topology and function</article-title><source>Nat. Rev.. Genet.</source><year>2014</year><volume>15</volume><fpage>234</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1038/nrg3663</pub-id><pub-id pub-id-type="pmid">24614316</pub-id>
</element-citation></ref><ref id="B72-viruses-16-01870"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stedman</surname><given-names>W.</given-names></name>
<name><surname>Kang</surname><given-names>H.</given-names></name>
<name><surname>Lin</surname><given-names>S.</given-names></name>
<name><surname>Kissil</surname><given-names>J.L.</given-names></name>
<name><surname>Bartolomei</surname><given-names>M.S.</given-names></name>
<name><surname>Lieberman</surname><given-names>P.M.</given-names></name>
</person-group><article-title>Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators</article-title><source>EMBO J.</source><year>2008</year><volume>27</volume><fpage>654</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1038/emboj.2008.1</pub-id><pub-id pub-id-type="pmid">18219272</pub-id>
</element-citation></ref><ref id="B73-viruses-16-01870"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Knipe</surname><given-names>D.M.</given-names></name>
<name><surname>Lieberman</surname><given-names>P.M.</given-names></name>
<name><surname>Jung</surname><given-names>J.U.</given-names></name>
<name><surname>McBride</surname><given-names>A.A.</given-names></name>
<name><surname>Morris</surname><given-names>K.V.</given-names></name>
<name><surname>Ott</surname><given-names>M.</given-names></name>
<name><surname>Margolis</surname><given-names>D.</given-names></name>
<name><surname>Nieto</surname><given-names>A.</given-names></name>
<name><surname>Nevels</surname><given-names>M.</given-names></name>
<name><surname>Parks</surname><given-names>R.J.</given-names></name>
<etal/>
</person-group><article-title>Snapshots: Chromatin control of viral infection</article-title><source>Virology</source><year>2013</year><volume>435</volume><fpage>141</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2012.09.023</pub-id><pub-id pub-id-type="pmid">23217624</pub-id>
</element-citation></ref><ref id="B74-viruses-16-01870"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kang</surname><given-names>H.</given-names></name>
<name><surname>Wiedmer</surname><given-names>A.</given-names></name>
<name><surname>Yuan</surname><given-names>Y.</given-names></name>
<name><surname>Robertson</surname><given-names>E.</given-names></name>
<name><surname>Lieberman</surname><given-names>P.M.</given-names></name>
</person-group><article-title>Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation</article-title><source>PLoS Pathog.</source><year>2011</year><volume>7</volume><elocation-id>e1002140</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002140</pub-id><pub-id pub-id-type="pmid">21876668</pub-id>
</element-citation></ref><ref id="B75-viruses-16-01870"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>D.J.</given-names></name>
<name><surname>Verma</surname><given-names>D.</given-names></name>
<name><surname>Mosbruger</surname><given-names>T.</given-names></name>
<name><surname>Swaminathan</surname><given-names>S.</given-names></name>
</person-group><article-title>CTCF and Rad21 act as host cell restriction factors for Kaposi&#x02019;s sarcoma-associated herpesvirus (KSHV) lytic replication by modulating viral gene transcription</article-title><source>PLoS Pathog</source><year>2014</year><volume>10</volume><elocation-id>e1003880</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003880</pub-id><pub-id pub-id-type="pmid">24415941</pub-id>
</element-citation></ref><ref id="B76-viruses-16-01870"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>H.S.</given-names></name>
<name><surname>Wikramasinghe</surname><given-names>P.</given-names></name>
<name><surname>Showe</surname><given-names>L.</given-names></name>
<name><surname>Lieberman</surname><given-names>P.M.</given-names></name>
</person-group><article-title>Cohesins repress Kaposi&#x02019;s sarcoma-associated herpesvirus immediate early gene transcription during latency</article-title><source>J. Virol.</source><year>2012</year><volume>86</volume><fpage>9454</fpage><lpage>9464</lpage><pub-id pub-id-type="doi">10.1128/JVI.00787-12</pub-id><pub-id pub-id-type="pmid">22740398</pub-id>
</element-citation></ref><ref id="B77-viruses-16-01870"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hark</surname><given-names>A.T.</given-names></name>
<name><surname>Schoenherr</surname><given-names>C.J.</given-names></name>
<name><surname>Katz</surname><given-names>D.J.</given-names></name>
<name><surname>Ingram</surname><given-names>R.S.</given-names></name>
<name><surname>Levorse</surname><given-names>J.M.</given-names></name>
<name><surname>Tilghman</surname><given-names>S.M.</given-names></name>
</person-group><article-title>CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus</article-title><source>Nature</source><year>2000</year><volume>405</volume><fpage>486</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1038/35013106</pub-id><pub-id pub-id-type="pmid">10839547</pub-id>
</element-citation></ref><ref id="B78-viruses-16-01870"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Han</surname><given-names>C.</given-names></name>
<name><surname>Zhang</surname><given-names>D.</given-names></name>
<name><surname>Gui</surname><given-names>C.</given-names></name>
<name><surname>Huang</surname><given-names>L.</given-names></name>
<name><surname>Chang</surname><given-names>S.</given-names></name>
<name><surname>Dong</surname><given-names>L.</given-names></name>
<name><surname>Bai</surname><given-names>L.</given-names></name>
<name><surname>Wu</surname><given-names>S.</given-names></name>
<name><surname>Lan</surname><given-names>K.</given-names></name>
</person-group><article-title>KSHV RTA antagonizes SMC5/6 complex-induced viral chromatin compaction by hijacking the ubiquitin-proteasome system</article-title><source>PLoS Pathog.</source><year>2022</year><volume>18</volume><elocation-id>e1010744</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1010744</pub-id><pub-id pub-id-type="pmid">35914008</pub-id>
</element-citation></ref><ref id="B79-viruses-16-01870"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ponting</surname><given-names>C.P.</given-names></name>
<name><surname>Oliver</surname><given-names>P.L.</given-names></name>
<name><surname>Reik</surname><given-names>W.</given-names></name>
</person-group><article-title>Evolution and functions of long noncoding RNAs</article-title><source>Cell</source><year>2009</year><volume>136</volume><fpage>629</fpage><lpage>641</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.02.006</pub-id><pub-id pub-id-type="pmid">19239885</pub-id>
</element-citation></ref><ref id="B80-viruses-16-01870"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>R.</given-names></name>
<name><surname>Lin</surname><given-names>S.F.</given-names></name>
<name><surname>Gradoville</surname><given-names>L.</given-names></name>
<name><surname>Miller</surname><given-names>G.</given-names></name>
</person-group><article-title>Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1996</year><volume>93</volume><fpage>11883</fpage><lpage>11888</lpage><pub-id pub-id-type="doi">10.1073/pnas.93.21.11883</pub-id><pub-id pub-id-type="pmid">8876232</pub-id>
</element-citation></ref><ref id="B81-viruses-16-01870"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rossetto</surname><given-names>C.C.</given-names></name>
<name><surname>Pari</surname><given-names>G.</given-names></name>
</person-group><article-title>KSHV PAN RNA associates with demethylases UTX and JMJD3 to activate lytic replication through a physical interaction with the virus genome</article-title><source>PLoS Pathog.</source><year>2012</year><volume>8</volume><elocation-id>e1002680</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002680</pub-id><pub-id pub-id-type="pmid">22589717</pub-id>
</element-citation></ref><ref id="B82-viruses-16-01870"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ito</surname><given-names>S.</given-names></name>
<name><surname>Horikawa</surname><given-names>S.</given-names></name>
<name><surname>Suzuki</surname><given-names>T.</given-names></name>
<name><surname>Kawauchi</surname><given-names>H.</given-names></name>
<name><surname>Tanaka</surname><given-names>Y.</given-names></name>
<name><surname>Suzuki</surname><given-names>T.</given-names></name>
<name><surname>Suzuki</surname><given-names>T.</given-names></name>
</person-group><article-title>Human NAT10 is an ATP-dependent RNA acetyltransferase responsible for N4-acetylcytidine formation in 18 S ribosomal RNA (rRNA)</article-title><source>J. Biol. Chem.</source><year>2014</year><volume>289</volume><fpage>35724</fpage><lpage>35730</lpage><pub-id pub-id-type="doi">10.1074/jbc.C114.602698</pub-id><pub-id pub-id-type="pmid">25411247</pub-id>
</element-citation></ref><ref id="B83-viruses-16-01870"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yan</surname><given-names>Q.</given-names></name>
<name><surname>Zhou</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>Z.</given-names></name>
<name><surname>Ding</surname><given-names>X.</given-names></name>
<name><surname>Ma</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>W.</given-names></name>
<name><surname>Jia</surname><given-names>X.</given-names></name>
<name><surname>Gao</surname><given-names>S.J.</given-names></name>
<name><surname>Lu</surname><given-names>C.</given-names></name>
</person-group><article-title>NAT10-dependent N(4)-acetylcytidine modification mediates PAN RNA stability, KSHV reactivation, and IFI16-related inflammasome activation</article-title><source>Nat. Commun.</source><year>2023</year><volume>14</volume><fpage>6327</fpage><pub-id pub-id-type="doi">10.1038/s41467-023-42135-3</pub-id><pub-id pub-id-type="pmid">37816771</pub-id>
</element-citation></ref><ref id="B84-viruses-16-01870"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yan</surname><given-names>Q.</given-names></name>
<name><surname>Zhou</surname><given-names>J.</given-names></name>
<name><surname>Gu</surname><given-names>Y.</given-names></name>
<name><surname>Huang</surname><given-names>W.</given-names></name>
<name><surname>Ruan</surname><given-names>M.</given-names></name>
<name><surname>Zhang</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>T.</given-names></name>
<name><surname>Wei</surname><given-names>P.</given-names></name>
<name><surname>Chen</surname><given-names>G.</given-names></name>
<name><surname>Li</surname><given-names>W.</given-names></name>
<etal/>
</person-group><article-title>Lactylation of NAT10 promotes N(4)-acetylcytidine modification on tRNA(Ser-CGA-1-1) to boost oncogenic DNA virus KSHV reactivation</article-title><source>Cell Death Differ.</source><year>2024</year><volume>31</volume><fpage>1362</fpage><lpage>1374</lpage><pub-id pub-id-type="doi">10.1038/s41418-024-01327-0</pub-id><pub-id pub-id-type="pmid">38879723</pub-id>
</element-citation></ref><ref id="B85-viruses-16-01870"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Campbell</surname><given-names>M.</given-names></name>
<name><surname>Kim</surname><given-names>K.Y.</given-names></name>
<name><surname>Chang</surname><given-names>P.C.</given-names></name>
<name><surname>Huerta</surname><given-names>S.</given-names></name>
<name><surname>Shevchenko</surname><given-names>B.</given-names></name>
<name><surname>Wang</surname><given-names>D.H.</given-names></name>
<name><surname>Izumiya</surname><given-names>C.</given-names></name>
<name><surname>Kung</surname><given-names>H.J.</given-names></name>
<name><surname>Izumiya</surname><given-names>Y.</given-names></name>
</person-group><article-title>A lytic viral long noncoding RNA modulates the function of a latent protein</article-title><source>J. Virol.</source><year>2014</year><volume>88</volume><fpage>1843</fpage><lpage>1848</lpage><pub-id pub-id-type="doi">10.1128/JVI.03251-13</pub-id><pub-id pub-id-type="pmid">24257619</pub-id>
</element-citation></ref><ref id="B86-viruses-16-01870"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cai</surname><given-names>X.</given-names></name>
<name><surname>Lu</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
<name><surname>Gonzalez</surname><given-names>C.M.</given-names></name>
<name><surname>Damania</surname><given-names>B.</given-names></name>
<name><surname>Cullen</surname><given-names>B.R.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2005</year><volume>102</volume><fpage>5570</fpage><lpage>5575</lpage><pub-id pub-id-type="doi">10.1073/pnas.0408192102</pub-id><pub-id pub-id-type="pmid">15800047</pub-id>
</element-citation></ref><ref id="B87-viruses-16-01870"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Samols</surname><given-names>M.A.</given-names></name>
<name><surname>Hu</surname><given-names>J.</given-names></name>
<name><surname>Skalsky</surname><given-names>R.L.</given-names></name>
<name><surname>Renne</surname><given-names>R.</given-names></name>
</person-group><article-title>Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi&#x02019;s sarcoma-associated herpesvirus</article-title><source>J. Virol.</source><year>2005</year><volume>79</volume><fpage>9301</fpage><lpage>9305</lpage><pub-id pub-id-type="doi">10.1128/JVI.79.14.9301-9305.2005</pub-id><pub-id pub-id-type="pmid">15994824</pub-id>
</element-citation></ref><ref id="B88-viruses-16-01870"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Liang</surname><given-names>D.</given-names></name>
<name><surname>Lan</surname><given-names>K.</given-names></name>
</person-group><article-title>MicroRNAs and unusual small RNAs discovered in Kaposi&#x02019;s sarcoma-associated herpesvirus virions</article-title><source>J. Virol.</source><year>2012</year><volume>86</volume><fpage>12717</fpage><lpage>12730</lpage><pub-id pub-id-type="doi">10.1128/JVI.01473-12</pub-id><pub-id pub-id-type="pmid">22973026</pub-id>
</element-citation></ref><ref id="B89-viruses-16-01870"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>X.</given-names></name>
<name><surname>Liang</surname><given-names>D.</given-names></name>
<name><surname>He</surname><given-names>Z.</given-names></name>
<name><surname>Deng</surname><given-names>Q.</given-names></name>
<name><surname>Robertson</surname><given-names>E.S.</given-names></name>
<name><surname>Lan</surname><given-names>K.</given-names></name>
</person-group><article-title>miR-K12-7-5p encoded by Kaposi&#x02019;s sarcoma-associated herpesvirus stabilizes the latent state by targeting viral ORF50/RTA</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><elocation-id>e16224</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0016224</pub-id><pub-id pub-id-type="pmid">21283761</pub-id>
</element-citation></ref><ref id="B90-viruses-16-01870"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bellare</surname><given-names>P.</given-names></name>
<name><surname>Ganem</surname><given-names>D.</given-names></name>
</person-group><article-title>Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: An evolutionary adaptation that fine-tunes lytic reactivation</article-title><source>Cell Host Microbe</source><year>2009</year><volume>6</volume><fpage>570</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2009.11.008</pub-id><pub-id pub-id-type="pmid">20006845</pub-id>
</element-citation></ref><ref id="B91-viruses-16-01870"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Plaisance-Bonstaff</surname><given-names>K.</given-names></name>
<name><surname>Choi</surname><given-names>H.S.</given-names></name>
<name><surname>Beals</surname><given-names>T.</given-names></name>
<name><surname>Krueger</surname><given-names>B.J.</given-names></name>
<name><surname>Boss</surname><given-names>I.W.</given-names></name>
<name><surname>Gay</surname><given-names>L.A.</given-names></name>
<name><surname>Haecker</surname><given-names>I.</given-names></name>
<name><surname>Hu</surname><given-names>J.</given-names></name>
<name><surname>Renne</surname><given-names>R.</given-names></name>
</person-group><article-title>KSHV miRNAs decrease expression of lytic genes in latently infected PEL and endothelial cells by targeting host transcription factors</article-title><source>Viruses</source><year>2014</year><volume>6</volume><fpage>4005</fpage><lpage>4023</lpage><pub-id pub-id-type="doi">10.3390/v6104005</pub-id><pub-id pub-id-type="pmid">25341664</pub-id>
</element-citation></ref><ref id="B92-viruses-16-01870"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>C.C.</given-names></name>
<name><surname>Li</surname><given-names>Z.</given-names></name>
<name><surname>Chu</surname><given-names>C.Y.</given-names></name>
<name><surname>Feng</surname><given-names>J.</given-names></name>
<name><surname>Feng</surname><given-names>J.</given-names></name>
<name><surname>Sun</surname><given-names>R.</given-names></name>
<name><surname>Rana</surname><given-names>T.M.</given-names></name>
</person-group><article-title>MicroRNAs encoded by Kaposi&#x02019;s sarcoma-associated herpesvirus regulate viral life cycle</article-title><source>EMBO Rep.</source><year>2010</year><volume>11</volume><fpage>784</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1038/embor.2010.132</pub-id><pub-id pub-id-type="pmid">20847741</pub-id>
</element-citation></ref><ref id="B93-viruses-16-01870"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Sun</surname><given-names>R.</given-names></name>
<name><surname>Lin</surname><given-names>X.</given-names></name>
<name><surname>Liang</surname><given-names>D.</given-names></name>
<name><surname>Deng</surname><given-names>Q.</given-names></name>
<name><surname>Lan</surname><given-names>K.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5</article-title><source>J. Virol.</source><year>2012</year><volume>86</volume><fpage>1372</fpage><lpage>1381</lpage><pub-id pub-id-type="doi">10.1128/JVI.06245-11</pub-id><pub-id pub-id-type="pmid">22013049</pub-id>
</element-citation></ref><ref id="B94-viruses-16-01870"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ziegelbauer</surname><given-names>J.M.</given-names></name>
<name><surname>Sullivan</surname><given-names>C.S.</given-names></name>
<name><surname>Ganem</surname><given-names>D.</given-names></name>
</person-group><article-title>Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs</article-title><source>Nat. Genet.</source><year>2009</year><volume>41</volume><fpage>130</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1038/ng.266</pub-id><pub-id pub-id-type="pmid">19098914</pub-id>
</element-citation></ref><ref id="B95-viruses-16-01870"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liang</surname><given-names>D.</given-names></name>
<name><surname>Gao</surname><given-names>Y.</given-names></name>
<name><surname>Lin</surname><given-names>X.</given-names></name>
<name><surname>He</surname><given-names>Z.</given-names></name>
<name><surname>Zhao</surname><given-names>Q.</given-names></name>
<name><surname>Deng</surname><given-names>Q.</given-names></name>
<name><surname>Lan</surname><given-names>K.</given-names></name>
</person-group><article-title>A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKK&#x003b5;</article-title><source>Cell Res.</source><year>2011</year><volume>21</volume><fpage>793</fpage><lpage>806</lpage><pub-id pub-id-type="doi">10.1038/cr.2011.5</pub-id><pub-id pub-id-type="pmid">21221132</pub-id>
</element-citation></ref><ref id="B96-viruses-16-01870"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mercier</surname><given-names>A.</given-names></name>
<name><surname>Arias</surname><given-names>C.</given-names></name>
<name><surname>Madrid</surname><given-names>A.S.</given-names></name>
<name><surname>Holdorf</surname><given-names>M.M.</given-names></name>
<name><surname>Ganem</surname><given-names>D.</given-names></name>
</person-group><article-title>Site-specific association with host and viral chromatin by Kaposi&#x02019;s sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation</article-title><source>J. Virol.</source><year>2014</year><volume>88</volume><fpage>6762</fpage><lpage>6777</lpage><pub-id pub-id-type="doi">10.1128/JVI.00268-14</pub-id><pub-id pub-id-type="pmid">24696474</pub-id>
</element-citation></ref><ref id="B97-viruses-16-01870"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Verma</surname><given-names>S.C.</given-names></name>
<name><surname>Borah</surname><given-names>S.</given-names></name>
<name><surname>Robertson</surname><given-names>E.S.</given-names></name>
</person-group><article-title>Latency-associated nuclear antigen of Kaposi&#x02019;s sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1</article-title><source>J. Virol.</source><year>2004</year><volume>78</volume><fpage>10348</fpage><lpage>10359</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.19.10348-10359.2004</pub-id><pub-id pub-id-type="pmid">15367601</pub-id>
</element-citation></ref><ref id="B98-viruses-16-01870"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saveliev</surname><given-names>A.</given-names></name>
<name><surname>Zhu</surname><given-names>F.</given-names></name>
<name><surname>Yuan</surname><given-names>Y.</given-names></name>
</person-group><article-title>Transcription mapping and expression patterns of genes in the major immediate-early region of Kaposi&#x02019;s sarcoma-associated herpesvirus</article-title><source>Virology</source><year>2002</year><volume>299</volume><fpage>301</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1006/viro.2002.1561</pub-id><pub-id pub-id-type="pmid">12202233</pub-id>
</element-citation></ref><ref id="B99-viruses-16-01870"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhu</surname><given-names>F.X.</given-names></name>
<name><surname>Cusano</surname><given-names>T.</given-names></name>
<name><surname>Yuan</surname><given-names>Y.</given-names></name>
</person-group><article-title>Identification of the immediate-early transcripts of Kaposi&#x02019;s sarcoma-associated herpesvirus</article-title><source>J. Virol.</source><year>1999</year><volume>73</volume><fpage>5556</fpage><lpage>5567</lpage><pub-id pub-id-type="doi">10.1128/JVI.73.7.5556-5567.1999</pub-id><pub-id pub-id-type="pmid">10364304</pub-id>
</element-citation></ref><ref id="B100-viruses-16-01870"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Butnaru</surname><given-names>M.</given-names></name>
<name><surname>Gaglia</surname><given-names>M.M.</given-names></name>
</person-group><article-title>Transcriptional and post-transcriptional regulation of viral gene expression in the gamma-herpesvirus Kaposi&#x02019;s sarcoma-associated herpesvirus</article-title><source>Curr. Clin. Microbiol. Rep.</source><year>2018</year><volume>5</volume><fpage>219</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1007/s40588-018-0102-1</pub-id><pub-id pub-id-type="pmid">30854283</pub-id>
</element-citation></ref><ref id="B101-viruses-16-01870"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garber</surname><given-names>A.C.</given-names></name>
<name><surname>Shu</surname><given-names>M.A.</given-names></name>
<name><surname>Hu</surname><given-names>J.</given-names></name>
<name><surname>Renne</surname><given-names>R.</given-names></name>
</person-group><article-title>DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi&#x02019;s sarcoma-associated herpesvirus</article-title><source>J. Virol.</source><year>2001</year><volume>75</volume><fpage>7882</fpage><lpage>7892</lpage><pub-id pub-id-type="doi">10.1128/JVI.75.17.7882-7892.2001</pub-id><pub-id pub-id-type="pmid">11483733</pub-id>
</element-citation></ref><ref id="B102-viruses-16-01870"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garber</surname><given-names>A.C.</given-names></name>
<name><surname>Hu</surname><given-names>J.</given-names></name>
<name><surname>Renne</surname><given-names>R.</given-names></name>
</person-group><article-title>Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication</article-title><source>J. Biol. Chem.</source><year>2002</year><volume>277</volume><fpage>27401</fpage><lpage>27411</lpage><pub-id pub-id-type="doi">10.1074/jbc.M203489200</pub-id><pub-id pub-id-type="pmid">12015325</pub-id>
</element-citation></ref><ref id="B103-viruses-16-01870"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lan</surname><given-names>K.</given-names></name>
<name><surname>Kuppers</surname><given-names>D.A.</given-names></name>
<name><surname>Verma</surname><given-names>S.C.</given-names></name>
<name><surname>Sharma</surname><given-names>N.</given-names></name>
<name><surname>Murakami</surname><given-names>M.</given-names></name>
<name><surname>Robertson</surname><given-names>E.S.</given-names></name>
</person-group><article-title>Induction of Kaposi&#x02019;s sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: A novel mechanism for establishment of latency</article-title><source>J. Virol.</source><year>2005</year><volume>79</volume><fpage>7453</fpage><lpage>7465</lpage><pub-id pub-id-type="doi">10.1128/JVI.79.12.7453-7465.2005</pub-id><pub-id pub-id-type="pmid">15919901</pub-id>
</element-citation></ref><ref id="B104-viruses-16-01870"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Verma</surname><given-names>S.C.</given-names></name>
<name><surname>Lan</surname><given-names>K.</given-names></name>
<name><surname>Choudhuri</surname><given-names>T.</given-names></name>
<name><surname>Robertson</surname><given-names>E.S.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats</article-title><source>J. Virol.</source><year>2006</year><volume>80</volume><fpage>3445</fpage><lpage>3458</lpage><pub-id pub-id-type="doi">10.1128/JVI.80.7.3445-3458.2006</pub-id><pub-id pub-id-type="pmid">16537612</pub-id>
</element-citation></ref><ref id="B105-viruses-16-01870"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Friborg</surname><given-names>J.</given-names><suffix>Jr.</suffix></name>
<name><surname>Kong</surname><given-names>W.</given-names></name>
<name><surname>Hottiger</surname><given-names>M.O.</given-names></name>
<name><surname>Nabel</surname><given-names>G.J.</given-names></name>
</person-group><article-title>p53 inhibition by the LANA protein of KSHV protects against cell death</article-title><source>Nature</source><year>1999</year><volume>402</volume><fpage>889</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.1038/47266</pub-id><pub-id pub-id-type="pmid">10622254</pub-id>
</element-citation></ref><ref id="B106-viruses-16-01870"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Radkov</surname><given-names>S.A.</given-names></name>
<name><surname>Kellam</surname><given-names>P.</given-names></name>
<name><surname>Boshoff</surname><given-names>C.</given-names></name>
</person-group><article-title>The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells</article-title><source>Nat Med.</source><year>2000</year><volume>6</volume><fpage>1121</fpage><lpage>1127</lpage><pub-id pub-id-type="doi">10.1038/80459</pub-id><pub-id pub-id-type="pmid">11017143</pub-id>
</element-citation></ref><ref id="B107-viruses-16-01870"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fujimuro</surname><given-names>M.</given-names></name>
<name><surname>Wu</surname><given-names>F.Y.</given-names></name>
<name><surname>ApRhys</surname><given-names>C.</given-names></name>
<name><surname>Kajumbula</surname><given-names>H.</given-names></name>
<name><surname>Young</surname><given-names>D.B.</given-names></name>
<name><surname>Hayward</surname><given-names>G.S.</given-names></name>
<name><surname>Hayward</surname><given-names>S.D.</given-names></name>
</person-group><article-title>A novel viral mechanism for dysregulation of beta-catenin in Kaposi&#x02019;s sarcoma-associated herpesvirus latency</article-title><source>Nat. Med.</source><year>2003</year><volume>9</volume><fpage>300</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1038/nm829</pub-id><pub-id pub-id-type="pmid">12592400</pub-id>
</element-citation></ref><ref id="B108-viruses-16-01870"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lim</surname><given-names>C.</given-names></name>
<name><surname>Sohn</surname><given-names>H.</given-names></name>
<name><surname>Gwack</surname><given-names>Y.</given-names></name>
<name><surname>Choe</surname><given-names>J.</given-names></name>
</person-group><article-title>Latency-associated nuclear antigen of Kaposi&#x02019;s sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity</article-title><source>J. Gen. Virol.</source><year>2000</year><volume>81</volume><fpage>2645</fpage><lpage>2652</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-81-11-2645</pub-id><pub-id pub-id-type="pmid">11038375</pub-id>
</element-citation></ref><ref id="B109-viruses-16-01870"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lim</surname><given-names>C.</given-names></name>
<name><surname>Gwack</surname><given-names>Y.</given-names></name>
<name><surname>Hwang</surname><given-names>S.</given-names></name>
<name><surname>Kim</surname><given-names>S.</given-names></name>
<name><surname>Choe</surname><given-names>J.</given-names></name>
</person-group><article-title>The transcriptional activity of cAMP response element-binding protein-binding protein is modulated by the latency associated nuclear antigen of Kaposi&#x02019;s sarcoma-associated herpesvirus</article-title><source>J. Biol. Chem.</source><year>2001</year><volume>276</volume><fpage>31016</fpage><lpage>31022</lpage><pub-id pub-id-type="doi">10.1074/jbc.M102431200</pub-id><pub-id pub-id-type="pmid">11425857</pub-id>
</element-citation></ref><ref id="B110-viruses-16-01870"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jeong</surname><given-names>J.H.</given-names></name>
<name><surname>Orvis</surname><given-names>J.</given-names></name>
<name><surname>Kim</surname><given-names>J.W.</given-names></name>
<name><surname>McMurtrey</surname><given-names>C.P.</given-names></name>
<name><surname>Renne</surname><given-names>R.</given-names></name>
<name><surname>Dittmer</surname><given-names>D.P.</given-names></name>
</person-group><article-title>Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi&#x02019;s sarcoma-associated herpesvirus</article-title><source>J. Biol. Chem.</source><year>2004</year><volume>279</volume><fpage>16822</fpage><lpage>16831</lpage><pub-id pub-id-type="doi">10.1074/jbc.M312801200</pub-id><pub-id pub-id-type="pmid">14742422</pub-id>
</element-citation></ref><ref id="B111-viruses-16-01870"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jeong</surname><given-names>J.</given-names></name>
<name><surname>Papin</surname><given-names>J.</given-names></name>
<name><surname>Dittmer</surname><given-names>D.</given-names></name>
</person-group><article-title>Differential regulation of the overlapping Kaposi&#x02019;s sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters</article-title><source>J. Virol.</source><year>2001</year><volume>75</volume><fpage>1798</fpage><lpage>1807</lpage><pub-id pub-id-type="doi">10.1128/JVI.75.4.1798-1807.2001</pub-id><pub-id pub-id-type="pmid">11160678</pub-id>
</element-citation></ref><ref id="B112-viruses-16-01870"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wei</surname><given-names>F.</given-names></name>
<name><surname>Gan</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>C.</given-names></name>
<name><surname>Zhu</surname><given-names>C.</given-names></name>
<name><surname>Cai</surname><given-names>Q.</given-names></name>
</person-group><article-title>Cell Cycle Regulatory Functions of the KSHV Oncoprotein LANA</article-title><source>Front. Microbiol.</source><year>2016</year><volume>7</volume><elocation-id>334</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2016.00334</pub-id><pub-id pub-id-type="pmid">27065950</pub-id>
</element-citation></ref><ref id="B113-viruses-16-01870"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Niu</surname><given-names>D.</given-names></name>
<name><surname>Ma</surname><given-names>Y.</given-names></name>
<name><surname>Ren</surname><given-names>P.</given-names></name>
<name><surname>Chang</surname><given-names>S.</given-names></name>
<name><surname>Li</surname><given-names>C.</given-names></name>
<name><surname>Jiang</surname><given-names>Y.</given-names></name>
<name><surname>Han</surname><given-names>C.</given-names></name>
<name><surname>Lan</surname><given-names>K.</given-names></name>
</person-group><article-title>Methylation of KSHV vCyclin by PRMT5 contributes to cell cycle progression and cell proliferation</article-title><source>PLoS Pathog.</source><year>2024</year><volume>20</volume><elocation-id>e1012535</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1012535</pub-id><pub-id pub-id-type="pmid">39255317</pub-id>
</element-citation></ref><ref id="B114-viruses-16-01870"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>X.</given-names></name>
<name><surname>Sun</surname><given-names>R.</given-names></name>
<name><surname>Zhang</surname><given-names>F.</given-names></name>
<name><surname>Gao</surname><given-names>Y.</given-names></name>
<name><surname>Bin</surname><given-names>L.</given-names></name>
<name><surname>Lan</surname><given-names>K.</given-names></name>
</person-group><article-title>The Latency-Associated Nuclear Antigen of Kaposi&#x02019;s Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency</article-title><source>J. Virol.</source><year>2017</year><volume>91</volume><pub-id pub-id-type="doi">10.1128/JVI.00806-17</pub-id></element-citation></ref><ref id="B115-viruses-16-01870"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Broussard</surname><given-names>G.</given-names></name>
<name><surname>Damania</surname><given-names>B.</given-names></name>
</person-group><article-title>Regulation of KSHV Latency and Lytic Reactivation</article-title><source>Viruses</source><year>2020</year><volume>12</volume><elocation-id>1034</elocation-id><pub-id pub-id-type="doi">10.3390/v12091034</pub-id><pub-id pub-id-type="pmid">32957532</pub-id>
</element-citation></ref><ref id="B116-viruses-16-01870"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>He</surname><given-names>M.</given-names></name>
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Bakken</surname><given-names>T.</given-names></name>
<name><surname>Schutten</surname><given-names>M.</given-names></name>
<name><surname>Toth</surname><given-names>Z.</given-names></name>
<name><surname>Jung</surname><given-names>J.U.</given-names></name>
<name><surname>Gill</surname><given-names>P.</given-names></name>
<name><surname>Cannon</surname><given-names>M.</given-names></name>
<name><surname>Gao</surname><given-names>S.J.</given-names></name>
</person-group><article-title>Cancer angiogenesis induced by Kaposi sarcoma-associated herpesvirus is mediated by EZH2</article-title><source>Cancer Res.</source><year>2012</year><volume>72</volume><fpage>3582</fpage><lpage>3592</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-11-2876</pub-id><pub-id pub-id-type="pmid">22593192</pub-id>
</element-citation></ref><ref id="B117-viruses-16-01870"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guito</surname><given-names>J.</given-names></name>
<name><surname>Lukac</surname><given-names>D.M.</given-names></name>
</person-group><article-title>KSHV Rta Promoter Specification and Viral Reactivation</article-title><source>Front. Microbiol.</source><year>2012</year><volume>3</volume><elocation-id>30</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2012.00030</pub-id><pub-id pub-id-type="pmid">22347875</pub-id>
</element-citation></ref><ref id="B118-viruses-16-01870"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gradoville</surname><given-names>L.</given-names></name>
<name><surname>Gerlach</surname><given-names>J.</given-names></name>
<name><surname>Grogan</surname><given-names>E.</given-names></name>
<name><surname>Shedd</surname><given-names>D.</given-names></name>
<name><surname>Nikiforow</surname><given-names>S.</given-names></name>
<name><surname>Metroka</surname><given-names>C.</given-names></name>
<name><surname>Miller</surname><given-names>G.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line</article-title><source>J. Virol.</source><year>2000</year><volume>74</volume><fpage>6207</fpage><lpage>6212</lpage><pub-id pub-id-type="doi">10.1128/JVI.74.13.6207-6212.2000</pub-id><pub-id pub-id-type="pmid">10846108</pub-id>
</element-citation></ref><ref id="B119-viruses-16-01870"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>S.E.</given-names></name>
<name><surname>Wu</surname><given-names>F.Y.</given-names></name>
<name><surname>Yu</surname><given-names>Y.</given-names></name>
<name><surname>Hayward</surname><given-names>G.S.</given-names></name>
</person-group><article-title>CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi&#x02019;s sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters</article-title><source>J. Virol.</source><year>2003</year><volume>77</volume><fpage>9590</fpage><lpage>9612</lpage><pub-id pub-id-type="doi">10.1128/jvi.77.17.9590-9612.2003</pub-id><pub-id pub-id-type="pmid">12915572</pub-id>
</element-citation></ref><ref id="B120-viruses-16-01870"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liao</surname><given-names>W.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
<name><surname>Kuo</surname><given-names>Y.L.</given-names></name>
<name><surname>Liu</surname><given-names>B.Y.</given-names></name>
<name><surname>Xu</surname><given-names>C.J.</given-names></name>
<name><surname>Giam</surname><given-names>C.Z.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus/human herpesvirus 8 transcriptional activator Rta is an oligomeric DNA-binding protein that interacts with tandem arrays of phased A/T-trinucleotide motifs</article-title><source>J. Virol.</source><year>2003</year><volume>77</volume><fpage>9399</fpage><lpage>9411</lpage><pub-id pub-id-type="doi">10.1128/JVI.77.17.9399-9411.2003</pub-id><pub-id pub-id-type="pmid">12915555</pub-id>
</element-citation></ref><ref id="B121-viruses-16-01870"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Verma</surname><given-names>S.C.</given-names></name>
<name><surname>Lan</surname><given-names>K.</given-names></name>
<name><surname>Robertson</surname><given-names>E.</given-names></name>
</person-group><article-title>Structure and function of latency-associated nuclear antigen</article-title><source>Curr. Top. Microbiol. Immunol.</source><year>2007</year><volume>312</volume><fpage>101</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1007/978-3-540-34344-8_4</pub-id><pub-id pub-id-type="pmid">17089795</pub-id>
</element-citation></ref><ref id="B122-viruses-16-01870"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>R.</given-names></name>
<name><surname>Lin</surname><given-names>S.F.</given-names></name>
<name><surname>Gradoville</surname><given-names>L.</given-names></name>
<name><surname>Yuan</surname><given-names>Y.</given-names></name>
<name><surname>Zhu</surname><given-names>F.</given-names></name>
<name><surname>Miller</surname><given-names>G.</given-names></name>
</person-group><article-title>A viral gene that activates lytic cycle expression of Kaposi&#x02019;s sarcoma-associated herpesvirus</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1998</year><volume>95</volume><fpage>10866</fpage><lpage>10871</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.18.10866</pub-id><pub-id pub-id-type="pmid">9724796</pub-id>
</element-citation></ref><ref id="B123-viruses-16-01870"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lukac</surname><given-names>D.M.</given-names></name>
<name><surname>Renne</surname><given-names>R.</given-names></name>
<name><surname>Kirshner</surname><given-names>J.R.</given-names></name>
<name><surname>Ganem</surname><given-names>D.</given-names></name>
</person-group><article-title>Reactivation of Kaposi&#x02019;s sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein</article-title><source>Virology</source><year>1998</year><volume>252</volume><fpage>304</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1006/viro.1998.9486</pub-id><pub-id pub-id-type="pmid">9878608</pub-id>
</element-citation></ref><ref id="B124-viruses-16-01870"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Deng</surname><given-names>H.</given-names></name>
<name><surname>Young</surname><given-names>A.</given-names></name>
<name><surname>Sun</surname><given-names>R.</given-names></name>
</person-group><article-title>Auto-activation of the rta gene of human herpesvirus-8/Kaposi&#x02019;s sarcoma-associated herpesvirus</article-title><source>J. Gen. Virol.</source><year>2000</year><volume>81</volume><fpage>3043</fpage><lpage>3048</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-81-12-3043</pub-id><pub-id pub-id-type="pmid">11086135</pub-id>
</element-citation></ref><ref id="B125-viruses-16-01870"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bu</surname><given-names>W.</given-names></name>
<name><surname>Palmeri</surname><given-names>D.</given-names></name>
<name><surname>Krishnan</surname><given-names>R.</given-names></name>
<name><surname>Marin</surname><given-names>R.</given-names></name>
<name><surname>Aris</surname><given-names>V.M.</given-names></name>
<name><surname>Soteropoulos</surname><given-names>P.</given-names></name>
<name><surname>Lukac</surname><given-names>D.M.</given-names></name>
</person-group><article-title>Identification of direct transcriptional targets of the Kaposi&#x02019;s sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localization</article-title><source>J. Virol.</source><year>2008</year><volume>82</volume><fpage>10709</fpage><lpage>10723</lpage><pub-id pub-id-type="doi">10.1128/JVI.01012-08</pub-id><pub-id pub-id-type="pmid">18715905</pub-id>
</element-citation></ref><ref id="B126-viruses-16-01870"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guito</surname><given-names>J.</given-names></name>
<name><surname>Lukac</surname><given-names>D.M.</given-names></name>
</person-group><article-title>KSHV reactivation and novel implications of protein isomerization on lytic switch control</article-title><source>Viruses</source><year>2015</year><volume>7</volume><fpage>72</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.3390/v7010072</pub-id><pub-id pub-id-type="pmid">25588053</pub-id>
</element-citation></ref><ref id="B127-viruses-16-01870"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ye</surname><given-names>F.</given-names></name>
<name><surname>Lei</surname><given-names>X.</given-names></name>
<name><surname>Gao</surname><given-names>S.J.</given-names></name>
</person-group><article-title>Mechanisms of Kaposi&#x02019;s Sarcoma-Associated Herpesvirus Latency and Reactivation</article-title><source>Adv. Virol.</source><year>2011</year><volume>2011</volume><fpage>193860</fpage><pub-id pub-id-type="doi">10.1155/2011/193860</pub-id><pub-id pub-id-type="pmid">21625290</pub-id>
</element-citation></ref><ref id="B128-viruses-16-01870"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chang</surname><given-names>P.J.</given-names></name>
<name><surname>Shedd</surname><given-names>D.</given-names></name>
<name><surname>Gradoville</surname><given-names>L.</given-names></name>
<name><surname>Cho</surname><given-names>M.S.</given-names></name>
<name><surname>Chen</surname><given-names>L.W.</given-names></name>
<name><surname>Chang</surname><given-names>J.</given-names></name>
<name><surname>Miller</surname><given-names>G.</given-names></name>
</person-group><article-title>Open reading frame 50 protein of Kaposi&#x02019;s sarcoma-associated herpesvirus directly activates the viral PAN and K12 genes by binding to related response elements</article-title><source>J. Virol.</source><year>2002</year><volume>76</volume><fpage>3168</fpage><lpage>3178</lpage><pub-id pub-id-type="doi">10.1128/JVI.76.7.3168-3178.2002</pub-id><pub-id pub-id-type="pmid">11884541</pub-id>
</element-citation></ref><ref id="B129-viruses-16-01870"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lukac</surname><given-names>D.M.</given-names></name>
<name><surname>Garibyan</surname><given-names>L.</given-names></name>
<name><surname>Kirshner</surname><given-names>J.R.</given-names></name>
<name><surname>Palmeri</surname><given-names>D.</given-names></name>
<name><surname>Ganem</surname><given-names>D.</given-names></name>
</person-group><article-title>DNA binding by Kaposi&#x02019;s sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters</article-title><source>J. Virol.</source><year>2001</year><volume>75</volume><fpage>6786</fpage><lpage>6799</lpage><pub-id pub-id-type="doi">10.1128/JVI.75.15.6786-6799.2001</pub-id><pub-id pub-id-type="pmid">11435557</pub-id>
</element-citation></ref><ref id="B130-viruses-16-01870"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Deng</surname><given-names>H.</given-names></name>
<name><surname>Song</surname><given-names>M.J.</given-names></name>
<name><surname>Chu</surname><given-names>J.T.</given-names></name>
<name><surname>Sun</surname><given-names>R.</given-names></name>
</person-group><article-title>Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi&#x02019;s sarcoma-associated herpesvirus)</article-title><source>J. Virol.</source><year>2002</year><volume>76</volume><fpage>8252</fpage><lpage>8264</lpage><pub-id pub-id-type="doi">10.1128/JVI.76.16.8252-8264.2002</pub-id><pub-id pub-id-type="pmid">12134031</pub-id>
</element-citation></ref><ref id="B131-viruses-16-01870"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chang</surname><given-names>P.J.</given-names></name>
<name><surname>Shedd</surname><given-names>D.</given-names></name>
<name><surname>Miller</surname><given-names>G.</given-names></name>
</person-group><article-title>Two subclasses of Kaposi&#x02019;s sarcoma-associated herpesvirus lytic cycle promoters distinguished by open reading frame 50 mutant proteins that are deficient in binding to DNA</article-title><source>J. Virol.</source><year>2005</year><volume>79</volume><fpage>8750</fpage><lpage>8763</lpage><pub-id pub-id-type="doi">10.1128/JVI.79.14.8750-8763.2005</pub-id><pub-id pub-id-type="pmid">15994769</pub-id>
</element-citation></ref><ref id="B132-viruses-16-01870"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liang</surname><given-names>Y.</given-names></name>
<name><surname>Ganem</surname><given-names>D.</given-names></name>
</person-group><article-title>Lytic but not latent infection by Kaposi&#x02019;s sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2003</year><volume>100</volume><fpage>8490</fpage><lpage>8495</lpage><pub-id pub-id-type="doi">10.1073/pnas.1432843100</pub-id><pub-id pub-id-type="pmid">12832621</pub-id>
</element-citation></ref><ref id="B133-viruses-16-01870"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Matsumura</surname><given-names>S.</given-names></name>
<name><surname>Fujita</surname><given-names>Y.</given-names></name>
<name><surname>Gomez</surname><given-names>E.</given-names></name>
<name><surname>Tanese</surname><given-names>N.</given-names></name>
<name><surname>Wilson</surname><given-names>A.C.</given-names></name>
</person-group><article-title>Activation of the Kaposi&#x02019;s sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50)</article-title><source>J. Virol.</source><year>2005</year><volume>79</volume><fpage>8493</fpage><lpage>8505</lpage><pub-id pub-id-type="doi">10.1128/JVI.79.13.8493-8505.2005</pub-id><pub-id pub-id-type="pmid">15956592</pub-id>
</element-citation></ref><ref id="B134-viruses-16-01870"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liang</surname><given-names>Y.</given-names></name>
<name><surname>Chang</surname><given-names>J.</given-names></name>
<name><surname>Lynch</surname><given-names>S.J.</given-names></name>
<name><surname>Lukac</surname><given-names>D.M.</given-names></name>
<name><surname>Ganem</surname><given-names>D.</given-names></name>
</person-group><article-title>The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway</article-title><source>Genes Dev.</source><year>2002</year><volume>16</volume><fpage>1977</fpage><lpage>1989</lpage><pub-id pub-id-type="doi">10.1101/gad.996502</pub-id><pub-id pub-id-type="pmid">12154127</pub-id>
</element-citation></ref><ref id="B135-viruses-16-01870"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>S.E.</given-names></name>
<name><surname>Wu</surname><given-names>F.Y.</given-names></name>
<name><surname>Fujimuro</surname><given-names>M.</given-names></name>
<name><surname>Zong</surname><given-names>J.</given-names></name>
<name><surname>Hayward</surname><given-names>S.D.</given-names></name>
<name><surname>Hayward</surname><given-names>G.S.</given-names></name>
</person-group><article-title>Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi&#x02019;s sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP</article-title><source>J. Virol.</source><year>2003</year><volume>77</volume><fpage>600</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1128/jvi.77.1.600-623.2003</pub-id><pub-id pub-id-type="pmid">12477864</pub-id>
</element-citation></ref><ref id="B136-viruses-16-01870"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>S.E.</given-names></name>
<name><surname>Wu</surname><given-names>F.Y.</given-names></name>
<name><surname>Chen</surname><given-names>H.</given-names></name>
<name><surname>Shamay</surname><given-names>M.</given-names></name>
<name><surname>Zheng</surname><given-names>Q.</given-names></name>
<name><surname>Hayward</surname><given-names>G.S.</given-names></name>
</person-group><article-title>Early activation of the Kaposi&#x02019;s sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway</article-title><source>J. Virol.</source><year>2004</year><volume>78</volume><fpage>4248</fpage><lpage>4267</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.8.4248-4267.2004</pub-id><pub-id pub-id-type="pmid">15047839</pub-id>
</element-citation></ref><ref id="B137-viruses-16-01870"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chang</surname><given-names>P.J.</given-names></name>
<name><surname>Boonsiri</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>S.S.</given-names></name>
<name><surname>Chen</surname><given-names>L.Y.</given-names></name>
<name><surname>Miller</surname><given-names>G.</given-names></name>
</person-group><article-title>Binding of RBP-Jkappa (CSL) protein to the promoter of the Kaposi&#x02019;s sarcoma-associated herpesvirus ORF47 (gL) gene is a critical but not sufficient determinant of transactivation by ORF50 protein</article-title><source>Virology</source><year>2010</year><volume>398</volume><fpage>38</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2009.11.022</pub-id><pub-id pub-id-type="pmid">20006367</pub-id>
</element-citation></ref><ref id="B138-viruses-16-01870"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Izumiya</surname><given-names>Y.</given-names></name>
<name><surname>Lin</surname><given-names>S.F.</given-names></name>
<name><surname>Ellison</surname><given-names>T.</given-names></name>
<name><surname>Chen</surname><given-names>L.Y.</given-names></name>
<name><surname>Izumiya</surname><given-names>C.</given-names></name>
<name><surname>Luciw</surname><given-names>P.</given-names></name>
<name><surname>Kung</surname><given-names>H.J.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: Physical association and promoter-dependent transcriptional repression</article-title><source>J. Virol.</source><year>2003</year><volume>77</volume><fpage>1441</fpage><lpage>1451</lpage><pub-id pub-id-type="doi">10.1128/JVI.77.2.1441-1451.2003</pub-id><pub-id pub-id-type="pmid">12502859</pub-id>
</element-citation></ref><ref id="B139-viruses-16-01870"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Roy Chowdhury</surname><given-names>N.</given-names></name>
<name><surname>Gurevich</surname><given-names>V.</given-names></name>
<name><surname>Shamay</surname><given-names>M.</given-names></name>
</person-group><article-title>KSHV genome harbors both constitutive and lytically induced enhancers</article-title><source>J. Virol.</source><year>2024</year><volume>98</volume><fpage>e0017924</fpage><pub-id pub-id-type="doi">10.1128/jvi.00179-24</pub-id><pub-id pub-id-type="pmid">38695538</pub-id>
</element-citation></ref><ref id="B140-viruses-16-01870"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ellison</surname><given-names>T.J.</given-names></name>
<name><surname>Izumiya</surname><given-names>Y.</given-names></name>
<name><surname>Izumiya</surname><given-names>C.</given-names></name>
<name><surname>Luciw</surname><given-names>P.A.</given-names></name>
<name><surname>Kung</surname><given-names>H.J.</given-names></name>
</person-group><article-title>A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi&#x02019;s sarcoma-associated herpesvirus</article-title><source>Virology</source><year>2009</year><volume>387</volume><fpage>76</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2009.02.016</pub-id><pub-id pub-id-type="pmid">19269659</pub-id>
</element-citation></ref><ref id="B141-viruses-16-01870"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gwack</surname><given-names>Y.</given-names></name>
<name><surname>Byun</surname><given-names>H.</given-names></name>
<name><surname>Hwang</surname><given-names>S.</given-names></name>
<name><surname>Lim</surname><given-names>C.</given-names></name>
<name><surname>Choe</surname><given-names>J.</given-names></name>
</person-group><article-title>CREB-binding protein and histone deacetylase regulate the transcriptional activity of Kaposi&#x02019;s sarcoma-associated herpesvirus open reading frame 50</article-title><source>J. Virol.</source><year>2001</year><volume>75</volume><fpage>1909</fpage><lpage>1917</lpage><pub-id pub-id-type="doi">10.1128/JVI.75.4.1909-1917.2001</pub-id><pub-id pub-id-type="pmid">11160690</pub-id>
</element-citation></ref><ref id="B142-viruses-16-01870"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Baresova</surname><given-names>P.</given-names></name>
<name><surname>Musilova</surname><given-names>J.</given-names></name>
<name><surname>Pitha</surname><given-names>P.M.</given-names></name>
<name><surname>Lubyova</surname><given-names>B.</given-names></name>
</person-group><article-title>p53 tumor suppressor protein stability and transcriptional activity are targeted by Kaposi&#x02019;s sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3</article-title><source>Mol. Cell. Biol.</source><year>2014</year><volume>34</volume><fpage>386</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1128/MCB.01011-13</pub-id><pub-id pub-id-type="pmid">24248600</pub-id>
</element-citation></ref><ref id="B143-viruses-16-01870"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hwang</surname><given-names>S.W.</given-names></name>
<name><surname>Kim</surname><given-names>D.</given-names></name>
<name><surname>Jung</surname><given-names>J.U.</given-names></name>
<name><surname>Lee</surname><given-names>H.R.</given-names></name>
</person-group><article-title>KSHV-encoded viral interferon regulatory factor 4 (vIRF4) interacts with IRF7 and inhibits interferon alpha production</article-title><source>Biochem Biophys Res Commun</source><year>2017</year><volume>486</volume><fpage>700</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2017.03.101</pub-id><pub-id pub-id-type="pmid">28342865</pub-id>
</element-citation></ref><ref id="B144-viruses-16-01870"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>S.C.</given-names></name>
<name><surname>Naik</surname><given-names>N.G.</given-names></name>
<name><surname>Tomb&#x000e1;cz</surname><given-names>D.</given-names></name>
<name><surname>Guly&#x000e1;s</surname><given-names>G.</given-names></name>
<name><surname>Kakuk</surname><given-names>B.</given-names></name>
<name><surname>Boldogk&#x00151;i</surname><given-names>Z.</given-names></name>
<name><surname>Hall</surname><given-names>K.</given-names></name>
<name><surname>Papp</surname><given-names>B.</given-names></name>
<name><surname>Boulant</surname><given-names>S.</given-names></name>
<name><surname>Toth</surname><given-names>Z.</given-names></name>
</person-group><article-title>Hypoxia and HIF-1&#x003b1; promote lytic de novo KSHV infection</article-title><source>J. Virol.</source><year>2023</year><volume>97</volume><fpage>e0097223</fpage><pub-id pub-id-type="doi">10.1128/jvi.00972-23</pub-id><pub-id pub-id-type="pmid">37909728</pub-id>
</element-citation></ref><ref id="B145-viruses-16-01870"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Chen</surname><given-names>S.</given-names></name>
<name><surname>Feng</surname><given-names>J.</given-names></name>
<name><surname>Deng</surname><given-names>H.</given-names></name>
<name><surname>Sun</surname><given-names>R.</given-names></name>
</person-group><article-title>Myc is required for the maintenance of Kaposi&#x02019;s sarcoma-associated herpesvirus latency</article-title><source>J. Virol.</source><year>2010</year><volume>84</volume><fpage>8945</fpage><lpage>8948</lpage><pub-id pub-id-type="doi">10.1128/JVI.00244-10</pub-id><pub-id pub-id-type="pmid">20573831</pub-id>
</element-citation></ref><ref id="B146-viruses-16-01870"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Luo</surname><given-names>T.</given-names></name>
<name><surname>Pan</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Zheng</surname><given-names>J.</given-names></name>
<name><surname>Zhuang</surname><given-names>Z.</given-names></name>
<name><surname>Ren</surname><given-names>Z.</given-names></name>
<name><surname>Zhu</surname><given-names>J.</given-names></name>
<name><surname>Gu</surname><given-names>Y.</given-names></name>
<name><surname>Zeng</surname><given-names>Y.</given-names></name>
</person-group><article-title>LANA regulates miR-155/GATA3 signaling axis by enhancing c-Jun/c-Fos interaction to promote the proliferation and migration of KSHV-infected cells</article-title><source>J Med. Virol</source><year>2023</year><volume>95</volume><fpage>e28255</fpage><pub-id pub-id-type="doi">10.1002/jmv.28255</pub-id><pub-id pub-id-type="pmid">36284455</pub-id>
</element-citation></ref><ref id="B147-viruses-16-01870"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>S.</given-names></name>
<name><surname>Liu</surname><given-names>S.</given-names></name>
<name><surname>Wu</surname><given-names>M.H.</given-names></name>
<name><surname>Geng</surname><given-names>Y.</given-names></name>
<name><surname>Wood</surname><given-names>C.</given-names></name>
</person-group><article-title>Identification of a cellular protein that interacts and synergizes with the RTA (ORF50) protein of Kaposi&#x02019;s sarcoma-associated herpesvirus in transcriptional activation</article-title><source>J. Virol.</source><year>2001</year><volume>75</volume><fpage>11961</fpage><lpage>11973</lpage><pub-id pub-id-type="doi">10.1128/JVI.75.24.11961-11973.2001</pub-id><pub-id pub-id-type="pmid">11711586</pub-id>
</element-citation></ref><ref id="B148-viruses-16-01870"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gwack</surname><given-names>Y.</given-names></name>
<name><surname>Nakamura</surname><given-names>H.</given-names></name>
<name><surname>Lee</surname><given-names>S.H.</given-names></name>
<name><surname>Souvlis</surname><given-names>J.</given-names></name>
<name><surname>Yustein</surname><given-names>J.T.</given-names></name>
<name><surname>Gygi</surname><given-names>S.</given-names></name>
<name><surname>Kung</surname><given-names>H.J.</given-names></name>
<name><surname>Jung</surname><given-names>J.U.</given-names></name>
</person-group><article-title>Poly(ADP-ribose) polymerase 1 and Ste20-like kinase hKFC act as transcriptional repressors for gamma-2 herpesvirus lytic replication</article-title><source>Mol. Cell. Biol.</source><year>2003</year><volume>23</volume><fpage>8282</fpage><lpage>8294</lpage><pub-id pub-id-type="doi">10.1128/MCB.23.22.8282-8294.2003</pub-id><pub-id pub-id-type="pmid">14585985</pub-id>
</element-citation></ref><ref id="B149-viruses-16-01870"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>C.</given-names></name>
<name><surname>Zhu</surname><given-names>C.</given-names></name>
<name><surname>Wei</surname><given-names>F.</given-names></name>
<name><surname>Gao</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Feng</surname><given-names>Y.</given-names></name>
<name><surname>Tong</surname><given-names>Y.</given-names></name>
<name><surname>Xu</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>B.</given-names></name>
<etal/>
</person-group><article-title>Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi&#x02019;s Sarcoma-Associated Herpesvirus for Viral Latency</article-title><source>PLoS Pathog.</source><year>2017</year><volume>13</volume><elocation-id>e1006124</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006124</pub-id><pub-id pub-id-type="pmid">28099521</pub-id>
</element-citation></ref><ref id="B150-viruses-16-01870"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wong</surname><given-names>L.Y.</given-names></name>
<name><surname>Matchett</surname><given-names>G.A.</given-names></name>
<name><surname>Wilson</surname><given-names>A.C.</given-names></name>
</person-group><article-title>Transcriptional activation by the Kaposi&#x02019;s sarcoma-associated herpesvirus latency-associated nuclear antigen is facilitated by an N-terminal chromatin-binding motif</article-title><source>J. Virol.</source><year>2004</year><volume>78</volume><fpage>10074</fpage><lpage>10085</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.18.10074-10085.2004</pub-id><pub-id pub-id-type="pmid">15331740</pub-id>
</element-citation></ref><ref id="B151-viruses-16-01870"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Keller</surname><given-names>S.A.</given-names></name>
<name><surname>Schattner</surname><given-names>E.J.</given-names></name>
<name><surname>Cesarman</surname><given-names>E.</given-names></name>
</person-group><article-title>Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells</article-title><source>Blood</source><year>2000</year><volume>96</volume><fpage>2537</fpage><lpage>2542</lpage><pub-id pub-id-type="doi">10.1182/blood.V96.7.2537.h8002537_2537_2542</pub-id><pub-id pub-id-type="pmid">11001908</pub-id>
</element-citation></ref><ref id="B152-viruses-16-01870"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Giffin</surname><given-names>L.</given-names></name>
<name><surname>West</surname><given-names>J.A.</given-names></name>
<name><surname>Damania</surname><given-names>B.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s Sarcoma-Associated Herpesvirus Interleukin-6 Modulates Endothelial Cell Movement by Upregulating Cellular Genes Involved in Migration</article-title><source>mBio</source><year>2015</year><volume>6</volume><fpage>e01499-15</fpage><pub-id pub-id-type="doi">10.1128/mBio.01499-15</pub-id><pub-id pub-id-type="pmid">26646010</pub-id>
</element-citation></ref><ref id="B153-viruses-16-01870"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>King</surname><given-names>C.A.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Barbachano-Guerrero</surname><given-names>A.</given-names></name>
<name><surname>Bhaduri-McIntosh</surname><given-names>S.</given-names></name>
</person-group><article-title>STAT3 Regulates Lytic Activation of Kaposi&#x02019;s Sarcoma-Associated Herpesvirus</article-title><source>J. Virol.</source><year>2015</year><volume>89</volume><fpage>11347</fpage><lpage>11355</lpage><pub-id pub-id-type="doi">10.1128/JVI.02008-15</pub-id><pub-id pub-id-type="pmid">26339061</pub-id>
</element-citation></ref><ref id="B154-viruses-16-01870"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tang</surname><given-names>J.</given-names></name>
<name><surname>Gordon</surname><given-names>G.M.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>M.G.</given-names></name>
<name><surname>Dahiya</surname><given-names>M.</given-names></name>
<name><surname>Foreman</surname><given-names>K.E.</given-names></name>
</person-group><article-title>Kaposi&#x02019;s sarcoma-associated herpesvirus latency-associated nuclear antigen induces expression of the helix-loop-helix protein Id-1 in human endothelial cells</article-title><source>J. Virol.</source><year>2003</year><volume>77</volume><fpage>5975</fpage><lpage>5984</lpage><pub-id pub-id-type="doi">10.1128/JVI.77.10.5975-5984.2003</pub-id><pub-id pub-id-type="pmid">12719589</pub-id>
</element-citation></ref><ref id="B155-viruses-16-01870"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gupta</surname><given-names>N.</given-names></name>
<name><surname>Thakker</surname><given-names>S.</given-names></name>
<name><surname>Verma</surname><given-names>S.C.</given-names></name>
</person-group><article-title>KSHV encoded LANA recruits Nucleosome Assembly Protein NAP1L1 for regulating viral DNA replication and transcription</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><elocation-id>32633</elocation-id><pub-id pub-id-type="doi">10.1038/srep32633</pub-id><pub-id pub-id-type="pmid">27599637</pub-id>
</element-citation></ref><ref id="B156-viruses-16-01870"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gjyshi</surname><given-names>O.</given-names></name>
<name><surname>Roy</surname><given-names>A.</given-names></name>
<name><surname>Dutta</surname><given-names>S.</given-names></name>
<name><surname>Veettil</surname><given-names>M.V.</given-names></name>
<name><surname>Dutta</surname><given-names>D.</given-names></name>
<name><surname>Chandran</surname><given-names>B.</given-names></name>
</person-group><article-title>Activated Nrf2 Interacts with Kaposi&#x02019;s Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression</article-title><source>J. Virol.</source><year>2015</year><volume>89</volume><fpage>7874</fpage><lpage>7892</lpage><pub-id pub-id-type="doi">10.1128/JVI.00895-15</pub-id><pub-id pub-id-type="pmid">25995248</pub-id>
</element-citation></ref><ref id="B157-viruses-16-01870"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>J.</given-names></name>
<name><surname>Verma</surname><given-names>S.C.</given-names></name>
<name><surname>Cai</surname><given-names>Q.</given-names></name>
<name><surname>Saha</surname><given-names>A.</given-names></name>
<name><surname>Dzeng</surname><given-names>R.K.</given-names></name>
<name><surname>Robertson</surname><given-names>E.S.</given-names></name>
</person-group><article-title>The RBP-J&#x003ba; binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation</article-title><source>PLoS Pathog.</source><year>2012</year><volume>8</volume><elocation-id>e1002479</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002479</pub-id><pub-id pub-id-type="pmid">22253595</pub-id>
</element-citation></ref><ref id="B158-viruses-16-01870"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>J.</given-names></name>
<name><surname>Verma</surname><given-names>S.C.</given-names></name>
<name><surname>Cai</surname><given-names>Q.</given-names></name>
<name><surname>Robertson</surname><given-names>E.S.</given-names></name>
</person-group><article-title>The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi&#x02019;s sarcoma-associated herpesvirus latency during primary infection</article-title><source>J. Virol.</source><year>2011</year><volume>85</volume><fpage>6148</fpage><lpage>6161</lpage><pub-id pub-id-type="doi">10.1128/JVI.02608-10</pub-id><pub-id pub-id-type="pmid">21507979</pub-id>
</element-citation></ref><ref id="B159-viruses-16-01870"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Papp</surname><given-names>B.</given-names></name>
<name><surname>Motlagh</surname><given-names>N.</given-names></name>
<name><surname>Smindak</surname><given-names>R.J.</given-names></name>
<name><surname>Jin Jang</surname><given-names>S.</given-names></name>
<name><surname>Sharma</surname><given-names>A.</given-names></name>
<name><surname>Alonso</surname><given-names>J.D.</given-names></name>
<name><surname>Toth</surname><given-names>Z.</given-names></name>
</person-group><article-title>Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi&#x02019;s Sarcoma-Associated Herpesvirus Lytic Reactivation</article-title><source>J. Virol.</source><year>2019</year><volume>93</volume><fpage>e01978-18</fpage><pub-id pub-id-type="doi">10.1128/JVI.01978-18</pub-id><pub-id pub-id-type="pmid">30541837</pub-id>
</element-citation></ref><ref id="B160-viruses-16-01870"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Deutsch</surname><given-names>E.</given-names></name>
<name><surname>Cohen</surname><given-names>A.</given-names></name>
<name><surname>Kazimirsky</surname><given-names>G.</given-names></name>
<name><surname>Dovrat</surname><given-names>S.</given-names></name>
<name><surname>Rubinfeld</surname><given-names>H.</given-names></name>
<name><surname>Brodie</surname><given-names>C.</given-names></name>
<name><surname>Sarid</surname><given-names>R.</given-names></name>
</person-group><article-title>Role of protein kinase C delta in reactivation of Kaposi&#x02019;s sarcoma-associated herpesvirus</article-title><source>J. Virol.</source><year>2004</year><volume>78</volume><fpage>10187</fpage><lpage>10192</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.18.10187-10192.2004</pub-id><pub-id pub-id-type="pmid">15331751</pub-id>
</element-citation></ref><ref id="B161-viruses-16-01870"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yu</surname><given-names>F.</given-names></name>
<name><surname>Harada</surname><given-names>J.N.</given-names></name>
<name><surname>Brown</surname><given-names>H.J.</given-names></name>
<name><surname>Deng</surname><given-names>H.</given-names></name>
<name><surname>Song</surname><given-names>M.J.</given-names></name>
<name><surname>Wu</surname><given-names>T.T.</given-names></name>
<name><surname>Kato-Stankiewicz</surname><given-names>J.</given-names></name>
<name><surname>Nelson</surname><given-names>C.G.</given-names></name>
<name><surname>Vieira</surname><given-names>J.</given-names></name>
<name><surname>Tamanoi</surname><given-names>F.</given-names></name>
<etal/>
</person-group><article-title>Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus</article-title><source>PLoS Pathog.</source><year>2007</year><volume>3</volume><elocation-id>e44</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.0030044</pub-id><pub-id pub-id-type="pmid">17397260</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="viruses-16-01870-f001"><label>Figure 1</label><caption><p>The chromatin landscape of the KSHV genome and the epigenetic regulatory mechanisms by which KSHV modulates its activity. (<bold>A</bold>) The chromatin landscape of the KSHV genome. During KSHV de novo infection, the initial viral genome is absent of histone marks. Within 24 h post-infection (hpi), the viral genome exhibits elevated levels of the activating histone marks H3K4me3 and H3K27ac. However, after 24 hpi, these activating marks begin to diminish, while the levels of repressive histone marks H3K27me3 and H2AK119ub increase significantly on the KSHV genome. (<bold>B</bold>) DNA methylation and KSHV infection: LANA interacts with DNMT3A, promoting the methylation and subsequent downregulation of the cadherin-13 promoter. LANA also binds to the promoter of the TGF-&#x003b2; type II receptor, inhibiting its expression through the induction of DNA methylation. vIL-6 enhances DNMT1 expression via STAT3 activation. vGPCR interacts with HIF1&#x003b1; and downregulates the expression of DNMT3A and DNMT3B. (<bold>C</bold>) Histone modifications repress KSHV transcription. Zeste homolog 2 (EZH2) binds to the KSHV genome and colocalizes with the repressive H3K27me3 mark to maintain KSHV latent infection. LANA recruits PRC2 to the KSHV genome and upregulates the level of H3K27me3 mark. In addition, LANA recruits and interacts with histone methyltransferase SUV39H1 and HP1 to induce H3K9 methylation of K1 and RTA, thus promoting the establishment of latent infection. (<bold>D</bold>) Histone modifications activate KSHV transcription. EZH2 dissociates from the KSHV genome, leading to downregulation of H3K27me3 mark to promote KSHV lytic replication. LANA interacts with the H3K9me1/2 demethylase KDM3A and promotes the removal of H3K9 methylation from the KSHV genome. LANA also interacts with the H3K4me3 methyltransferase hSET1, resulting in the deposition of H3K4me3 on the KSHV genome. PAN RNA interacts with H3K27me3 demethylases UTX and JMJD3 and removes H3K27me3 from the KSHV genome. ORF59 interacts with JMJD3, resulting in the decrease in H3K27me3. ORF59 also interacts with PRMT5 and disrupts its association with COPR5, leading to an increase in H3K4me3.</p></caption><graphic xlink:href="viruses-16-01870-g001" position="float"/></fig><fig position="float" id="viruses-16-01870-f002"><label>Figure 2</label><caption><p>The schematic representation of gene expression and regulatory factors during the latency and lytic phases of KSHV infection. (<bold>A</bold>) A schematic depiction of the primary latency locus in KSHV. Middle panel: the four primary open reading frames (ORFs)-ORF73, ORF72, ORF71, and K12 alongside 12 pre-miRNA sequences are represented by vertical arrows in a light blue color. Top and Bottom panel: the transcriptional profiles directed by the Kaposin promoter (LTd) and the LANA promoter (LTc), respectively. (<bold>B</bold>) A schematic depiction of the sequential gene expression profile during the KSHV lytic phase is presented. The first set of genes expressed are referred to as the immediate-early (IE) genes, which includes RTA, etc. The second temporal class of mRNAs includes delayed-early (DE) genes, which includes K-bZIP, etc. Following the initiation of replication, late (L) genes are synthesized. These genes encode viral structural proteins, including gB, etc. RBP-j&#x003ba; binding sites within the RTA promoter have been found to be critical for LANA-mediated repression. vDNA repl, viral DNA replication. (<bold>C</bold>) The identified LANA and RTA-responsive genes and associated proteins are shown.</p></caption><graphic xlink:href="viruses-16-01870-g002" position="float"/></fig></floats-group></article>